| placebo |
placebo |
223 |
2014 |
| Drug |
vancomycin |
48 |
2013 |
| Drug |
zidovudine |
44 |
1999 |
| Drug |
sof |
37 |
2014 |
| Drug |
ritonavir |
28 |
2013 |
| Drug |
linezolid |
25 |
2014 |
| Drug |
ribavirin |
25 |
2010 |
| Drug |
azithromycin |
24 |
2017 |
| Drug |
metronidazole |
23 |
2013 |
| Drug |
meropenem |
22 |
2013 |
| Drug |
rbv |
22 |
2016 |
| Drug |
standard care |
22 |
2010 |
| Drug |
vel |
19 |
2017 |
| Drug |
amoxicillin |
18 |
2013 |
| Drug |
clarithromycin |
18 |
2013 |
| Drug |
lamivudine |
18 |
2017 |
| Drug |
sof/vel |
18 |
2017 |
| Drug |
ldv |
16 |
2017 |
| Drug |
ldv/sof |
16 |
2017 |
| Drug |
didanosine |
15 |
2005 |
| Drug |
fluconazole |
15 |
2016 |
| Other |
blood sample |
14 |
2010 |
| Drug |
emtricitabine |
14 |
2013 |
| Drug |
levofloxacin |
14 |
2010 |
| Drug |
r |
14 |
2014 |
| Drug |
tigecycline |
14 |
2013 |
| Drug |
abt-450 |
13 |
2011 |
| Drug |
ganciclovir |
13 |
2018 |
| Drug |
rifabutin |
13 |
2013 |
| Drug |
daptomycin |
12 |
2009 |
| Drug |
tazobactam |
12 |
2017 |
| Drug |
tenofovir |
12 |
2013 |
| Other |
laboratory biomarker analysis |
11 |
2015 |
| Drug |
raltegravir |
11 |
2010 |
| Drug |
ciprofloxacin |
10 |
2019 |
| Drug |
stavudine |
10 |
2003 |
| Drug |
acyclovir |
9 |
2009 |
| Drug |
efavirenz |
9 |
2015 |
| Drug |
ethambutol hydrochloride |
9 |
1999 |
| Drug |
imipenem |
9 |
2011 |
| Drug |
sofosbuvir |
9 |
2014 |
| Drug |
valacyclovir |
9 |
2013 |
| Drug |
zalcitabine |
9 |
1999 |
| Drug |
doripenem |
8 |
2011 |
| Drug |
itraconazole |
8 |
2010 |
| Drug |
nevirapine |
8 |
2005 |
| Drug |
ribavirin (rbv) |
8 |
2014 |
| Drug |
abacavir |
7 |
2007 |
| Drug |
abt-267 |
7 |
2014 |
| Drug |
albendazole |
7 |
2010 |
| Drug |
aztreonam |
7 |
2013 |
| Drug |
cilastatin |
7 |
2011 |
| Drug |
ertapenem |
7 |
2017 |
| Drug |
hydroxychloroquine |
7 |
2020 |
| Drug |
kg |
7 |
2016 |
| Drug |
maraviroc |
7 |
2009 |
| Drug |
nelfinavir mesylate |
7 |
2001 |
| Drug |
piperacillin |
7 |
2018 |
| Drug |
posaconazole |
7 |
2020 |
| Drug |
saline |
7 |
2011 |
| Drug |
valganciclovir |
7 |
2013 |
| Dietary Supplement |
vitamin d |
7 |
2014 |
| Drug |
abacavir sulfate |
6 |
2005 |
| Drug |
abt-267, abt-333 |
6 |
2013 |
| Drug |
abt-333 |
6 |
2009 |
| Drug |
abt-450/r/abt-267, abt-333 |
6 |
2013 |
| Drug |
atazanavir |
6 |
2013 |
| Drug |
cefazolin |
6 |
2015 |
| Drug |
ceftriaxone |
6 |
2019 |
| Drug |
chlorhexidine gluconate |
6 |
2010 |
| Drug |
clindamycin |
6 |
2014 |
| Drug |
dalbavancin |
6 |
2017 |
| Drug |
darunavir |
6 |
2009 |
| Drug |
dasabuvir |
6 |
2014 |
| Drug |
dolutegravir |
6 |
2016 |
| Drug |
doxycycline |
6 |
2019 |
| Other |
fecal microbiota transplantation |
6 |
2017 |
| Drug |
fidaxomicin |
6 |
2016 |
| Drug |
isoniazid |
6 |
2007 |
| Drug |
lopinavir |
6 |
2009 |
| Drug |
ombitasvir |
6 |
2015 |
| Drug |
paritaprevir |
6 |
2015 |
| Drug |
voriconazole |
6 |
2012 |
| Drug |
vox |
6 |
2015 |
| Drug |
3tc |
5 |
2014 |
| Drug |
abt-450/r/abt-267 |
5 |
2014 |
| Drug |
antibiotics |
5 |
2019 |
| Drug |
ceftolozane |
5 |
2017 |
| Drug |
ceftriaxone sodium |
5 |
2010 |
| Drug |
cephalexin |
5 |
2012 |
| Drug |
chlorhexidine |
5 |
2015 |
| Drug |
delafloxacin |
5 |
2013 |
| Drug |
esomeprazole |
5 |
2013 |
| Drug |
foscarnet sodium |
5 |
1999 |
| Drug |
imipenem/cilastatin |
5 |
2012 |
| Biological |
inactivated, split-virion influenza vaccine |
5 |
2008 |
| Drug |
indinavir sulfate |
5 |
2000 |
| Drug |
lopinavir/ritonavir |
5 |
2009 |
| Drug |
mupirocin |
5 |
2012 |
| Drug |
omeprazole |
5 |
2017 |
| Drug |
piperacillin/tazobactam |
5 |
2018 |
| Drug |
sargramostim |
5 |
1999 |
| Drug |
tdf |
5 |
2018 |
| Drug |
telavancin |
5 |
2011 |
| Drug |
tenofovir disoproxil fumarate |
5 |
2017 |
| Drug |
trimethoprim |
5 |
2020 |
| Biological |
a |
4 |
2015 |
| Drug |
aldesleukin |
4 |
2000 |
| Drug |
cefepime |
4 |
2015 |
| Drug |
ceftaroline |
4 |
2015 |
| Drug |
ceftobiprole |
4 |
2009 |
| Drug |
cefuroxime |
4 |
2010 |
| Drug |
clofazimine |
4 |
1999 |
| Biological |
convalescent plasma |
4 |
2020 |
| Drug |
ergoferon |
4 |
2016 |
| Drug |
hydroxyurea |
4 |
1999 |
| Drug |
lamivudine (3tc) |
4 |
2016 |
| Drug |
losartan |
4 |
2012 |
| Drug |
mk0826, ertapenem sodium |
4 |
2004 |
| Drug |
nitrofurantoin |
4 |
2010 |
| placebo |
placebo for ribavirin |
4 |
2013 |
| placebo |
placebo for vrc01 |
4 |
2015 |
| Drug |
soc |
4 |
2013 |
| Drug |
sof/vel/vox |
4 |
2015 |
| Drug |
sulfamethoxazole |
4 |
2017 |
| Drug |
telmisartan |
4 |
2014 |
| Drug |
temocillin |
4 |
2015 |
| Drug |
thalidomide |
4 |
1999 |
| Drug |
trimethoprim-sulfamethoxazole |
4 |
2008 |
| Biological |
vrc01 |
4 |
2015 |
| Drug |
abacavir/lamivudine |
3 |
2004 |
| Drug |
abt-493 |
3 |
2015 |
| Drug |
abt-493/abt-530 |
3 |
2015 |
| Drug |
abt-530 |
3 |
2015 |
| Biological |
alhydrogel |
3 |
2013 |
| Drug |
amprenavir |
3 |
1999 |
| Drug |
antibiotic |
3 |
2011 |
| Behavioral |
audit |
3 |
2017 |
| Biological |
b |
3 |
2015 |
| Drug |
best available therapy |
3 |
2016 |
| Dietary Supplement |
bifidobacterium animalis subsp. lactis |
3 |
2012 |
| Biological |
biological samples |
3 |
2020 |
| Procedure |
blood draw |
3 |
2009 |
| Drug |
boceprevir |
3 |
2012 |
| Drug |
caspofungin acetate |
3 |
2011 |
| Drug |
ceftaroline fosamil |
3 |
2011 |
| Drug |
ceftazidime |
3 |
2009 |
| Drug |
ceftazidime - avibactam ( caz-avi) |
3 |
2012 |
| Drug |
ceftobiprole medocaril |
3 |
2017 |
| Drug |
cipro xr (ciprofloxacin, bayq3939) |
3 |
2007 |
| Drug |
clavulanate |
3 |
2014 |
| Drug |
clavulanic acid |
3 |
2008 |
| Drug |
comparator: ceftriaxone sodium |
3 |
2009 |
| Behavioral |
control |
3 |
2019 |
| Biological |
cranberry juice |
3 |
2013 |
| Drug |
dapsone |
3 |
1999 |
| Drug |
dexamethasone |
3 |
2011 |
| Drug |
dtg |
3 |
2016 |
| Drug |
emtricitabine (tdf |
3 |
2016 |
| Drug |
eravacycline |
3 |
2017 |
| Drug |
ertapenem sodium |
3 |
2010 |
| Drug |
everolimus |
3 |
2012 |
| Drug |
fosamprenavir |
3 |
2008 |
| Drug |
gepotidacin |
3 |
2018 |
| Drug |
gsk1349572 |
3 |
2010 |
| Other |
hand sanitizer |
3 |
2012 |
| Drug |
heparin |
3 |
2016 |
| Behavioral |
household cleaning |
3 |
2015 |
| Drug |
ingavirin |
3 |
2017 |
| Drug |
iv vancomycin |
3 |
2010 |
| Drug |
lamivudine/zidovudine |
3 |
2001 |
| placebo |
linezolid placebo |
3 |
2015 |
| Drug |
mebendazole |
3 |
2014 |
| Drug |
moxifloxacin (avelox, bay12-8039) |
3 |
2010 |
| Other |
no intervention |
3 |
2015 |
| Drug |
omadacycline |
3 |
2016 |
| Drug |
ombitasvir/paritaprevir/ritonavir |
3 |
2014 |
| Drug |
ombitasvir/paritaprevir/ritonavir/dasabuvir |
3 |
2015 |
| Drug |
oritavancin |
3 |
2015 |
| placebo |
placebo for abt-333 |
3 |
2009 |
| Drug |
plazomicin |
3 |
2013 |
| Dietary Supplement |
probiotics |
3 |
2011 |
| Drug |
pyridoxine hydrochloride |
3 |
1999 |
| Drug |
rbx2660 |
3 |
2017 |
| Drug |
ridinilazole |
3 |
2018 |
| Drug |
rifampicin |
3 |
2017 |
| Drug |
rifampin |
3 |
1999 |
| Other |
standard wound care |
3 |
2019 |
| Drug |
sulbactam |
3 |
2016 |
| Drug |
sulfamethoxazole-trimethoprim |
3 |
1999 |
| Drug |
telaprevir |
3 |
2013 |
| Drug |
trimethoprim/sulfamethoxazole |
3 |
2012 |
| Drug |
valacyclovir hydrochloride |
3 |
1999 |
| Device |
vicryl plus |
3 |
2009 |
| Drug |
NA |
2 |
2011 |
| Drug |
160 mg of sulfamethoxazole |
2 |
2012 |
| Drug |
2% chlorhexidine gluconate cloth |
2 |
2018 |
| Drug |
2% mupirocin ointment |
2 |
2008 |
| Biological |
30 âµg |
2 |
2016 |
| Biological |
30 âµg/strain of quadrivalent vlp vaccine |
2 |
2016 |
| Biological |
a/h5n1 inactivated, split virion pandemic influenza vaccine |
2 |
2009 |
| Drug |
ab103 0.5 mg |
2 |
2011 |
| Drug |
ab103 0.5 mg/kg |
2 |
2011 |
| Drug |
abc |
2 |
2014 |
| Drug |
amox |
2 |
2015 |
| Drug |
amoxicillin/clavulanate |
2 |
2014 |
| Drug |
amphotericin b |
2 |
1999 |
| Drug |
antistaphylococcal penicillin |
2 |
2004 |
| Drug |
at-527 |
2 |
2019 |
| Behavioral |
audit/feedback: peer comparison |
2 |
2011 |
| Drug |
avelox (moxifloxacin, bay12-8039) |
2 |
2009 |
| Drug |
azli |
2 |
2017 |
| Biological |
bezlotoxumab |
2 |
2017 |
| Drug |
bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline) |
2 |
2015 |
| Procedure |
blood collection |
2 |
2015 |
| Drug |
capravirine |
2 |
1999 |
| Drug |
caz-avi |
2 |
2013 |
| Drug |
cd4-igg |
2 |
1999 |
| Behavioral |
cds order sets: suggested alternatives |
2 |
2011 |
| Drug |
cefiderocol |
2 |
2019 |
| Drug |
cefixime |
2 |
2019 |
| Drug |
cefotaxime |
2 |
2016 |
| Drug |
ceftazidime -avibactam |
2 |
2015 |
| Biological |
cervarix |
2 |
2017 |
| Drug |
chlorhexidine-alcohol |
2 |
2018 |
| Device |
chlorhexidine-impregnated foam dressing |
2 |
2007 |
| Drug |
clotrimazole |
2 |
1999 |
| Biological |
cmv |
2 |
2018 |
| Drug |
cmx001 |
2 |
2009 |
| Drug |
cmx157 |
2 |
2016 |
| Drug |
co-amoxiclav |
2 |
2018 |
| Drug |
coated vicryl plus |
2 |
2020 |
| Drug |
cobicistat |
2 |
2017 |
| Drug |
colistin |
2 |
2013 |
| Drug |
comparator |
2 |
2016 |
| Drug |
cotrimoxazole |
2 |
2017 |
| Drug |
crofelemer |
2 |
1999 |
| Drug |
cxa-101 |
2 |
2009 |
| Drug |
cxa-201 |
2 |
2011 |
| Drug |
d-plex |
2 |
2016 |
| Drug |
daclatasvir |
2 |
2019 |
| Other |
dietary intervention |
2 |
2019 |
| Behavioral |
disinfection |
2 |
2007 |
| Drug |
dolutegravir (dtg) |
2 |
2016 |
| Drug |
dornase alfa |
2 |
2011 |
| Drug |
duration of treatment : 8 weeks |
2 |
2007 |
| Drug |
duration of treatment: 14 days |
2 |
2007 |
| Drug |
ebr |
2 |
2017 |
| Behavioral |
educational material |
2 |
2019 |
| Drug |
either switch to oral therapy: 500 mg of ciprofloxacin (oral) |
2 |
2012 |
| Drug |
enfuvirtide |
2 |
2015 |
| Drug |
enfuvirtide [fuzeon] |
2 |
2006 |
| Drug |
entecavir |
2 |
2015 |
| Drug |
epclusa |
2 |
2018 |
| Drug |
ethanol |
2 |
2009 |
| Drug |
f |
2 |
2016 |
| Drug |
fecal microbiota transplant |
2 |
2017 |
| Biological |
fecal microbiota transplant (fmt) |
2 |
2016 |
| Behavioral |
feedback |
2 |
2017 |
| Behavioral |
feedback: peer comparison |
2 |
2011 |
| Dietary Supplement |
fermented milk |
2 |
2013 |
| Drug |
foscarnet |
2 |
2016 |
| Drug |
fosfomycin |
2 |
2017 |
| Drug |
fosfomycin-trometamol |
2 |
2013 |
| Drug |
ftc fdc) |
2 |
2016 |
| Drug |
gentamicin |
2 |
2016 |
| Drug |
gentamicin-collagen sponge dipped in saline |
2 |
2008 |
| Drug |
gentamicin sulfate |
2 |
2018 |
| Drug |
gs-9190 |
2 |
2010 |
| Drug |
gsk1265744 30 mg |
2 |
2012 |
| Biological |
h5n1 inactivated, split virion pandemic influenza vaccine |
2 |
2009 |
| Drug |
haart |
2 |
2008 |
| Other |
health information prescription |
2 |
2010 |
| Biological |
hiberixâ„¢ vaccine |
2 |
2009 |
| Drug |
high-dose dual therapy (rabeprazole, amoxicillin) |
2 |
2015 |
| Biological |
high dose of quadrivalent vlp vaccine |
2 |
2014 |
| Drug |
highly active antiretroviral therapy (haart) |
2 |
2008 |
| Biological |
hiv-1 immunogen |
2 |
1999 |
| Behavioral |
hygiene protocol |
2 |
2008 |
| Drug |
imi |
2 |
2017 |
| Drug |
imipenem-cilastatin |
2 |
2018 |
| Drug |
imipenem/cilastatin/relebactam |
2 |
2015 |
| Other |
infectious disease specialist advice |
2 |
2010 |
| Biological |
influenza virus vaccine usp trivalent types a |
2 |
2008 |
| Biological |
influenza virus vaccine usp trivalent types a/b |
2 |
2008 |
| Drug |
interferon alfa-2a |
2 |
1999 |
| Drug |
interferon alfa-2b |
2 |
1999 |
| Drug |
interferon alfa-n1 |
2 |
1999 |
| Drug |
interleukin-12 |
2 |
1999 |
| placebo |
intravenous placebo |
2 |
2020 |
| Drug |
ivermectin |
2 |
2020 |
| Combination Product |
lactobacillus reuteri |
2 |
2012 |
| Dietary Supplement |
lactobacillus rhamnosus gg |
2 |
2015 |
| Drug |
lansoprazole |
2 |
2019 |
| Biological |
lbvh0101 (hib vaccine) |
2 |
2009 |
| Drug |
letermovir |
2 |
2018 |
| Procedure |
leukapheresis |
2 |
2001 |
| Drug |
levo |
2 |
2015 |
| Drug |
lexiva (gw433908) |
2 |
2004 |
| Biological |
low dose of quadrivalent vlp vaccine |
2 |
2014 |
| Biological |
lyophilized fecal microbiota transplantation |
2 |
2019 |
| Drug |
maxipim |
2 |
2018 |
| Other |
medical thoracoscopy |
2 |
2016 |
| Biological |
medium dose of quadrivalent vlp vaccine |
2 |
2014 |
| Procedure |
microdialysis catheter insertion |
2 |
2015 |
| Biological |
mk-3415a |
2 |
2012 |
| Biological |
mk-6072 |
2 |
2012 |
| Drug |
mk-7625a 1.5 g (ceftolozane 1 g |
2 |
2016 |
| Drug |
mk-7625a 1.5 g (ceftolozane 1 g/tazobactam 0.5 g) |
2 |
2016 |
| Drug |
mk0826, |
2 |
2007 |
| Drug |
mk0826, /duration of treatment : 8 weeks |
2 |
2007 |
| Device |
mngs for pathogen detection |
2 |
2019 |
| Drug |
moxifloxacin |
2 |
2009 |
| Drug |
mucinex |
2 |
2012 |
| Drug |
mupirocin calcium ointment, 2% |
2 |
2011 |
| Drug |
mupirocin ointment |
2 |
2015 |
| Device |
negative pressure wound therapy |
2 |
2013 |
| Drug |
nitric oxide |
2 |
2020 |
| Drug |
nystatin |
2 |
1999 |
| Drug |
or switch to oral therapy: 800 mg |
2 |
2012 |
| Drug |
or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral) |
2 |
2012 |
| Drug |
oral vancomycin |
2 |
2018 |
| Device |
pack-cxl |
2 |
2016 |
| Biological |
palivizumab |
2 |
2009 |
| Drug |
peginterferon alfa-2a |
2 |
2010 |
| Drug |
pegylated interferon |
2 |
2009 |
| Drug |
pegylated interferon alfa-2a |
2 |
2011 |
| Drug |
penn microbiome therapy - 001 |
2 |
2019 |
| Drug |
penn microbiome therapy - 002 |
2 |
2019 |
| Drug |
penn microbiome therapy - 003 |
2 |
2019 |
| Biological |
pennvax-b |
2 |
2010 |
| Drug |
pentamidine isethionate |
2 |
1999 |
| Drug |
piperacillin-tazobactam |
2 |
2016 |
| placebo |
placebo for abt-450 |
2 |
2012 |
| Drug |
placebo for abt-450/r/abt-267 |
2 |
2012 |
| placebo |
placebo juice |
2 |
2013 |
| placebo |
placebo maltodextrin |
2 |
2018 |
| placebo |
placebo matching gepotidacin |
2 |
2019 |
| placebo |
placebo matching nitrofurantoin |
2 |
2019 |
| Biological |
pneumococcal conjugate vaccine, heptavalent |
2 |
1999 |
| Biological |
pneumococcal vaccine formulation 1 |
2 |
2011 |
| Biological |
pneumococcal vaccine formulation 2 |
2 |
2011 |
| Biological |
pneumococcal vaccine formulation 3 |
2 |
2011 |
| Biological |
pneumococcal vaccine, polyvalent (23-valent) |
2 |
1999 |
| Drug |
prebiotics |
2 |
2019 |
| Drug |
presatovir |
2 |
2014 |
| Device |
prevena incision management system |
2 |
2016 |
| Drug |
pro 2000 |
2 |
2005 |
| Dietary Supplement |
probiotic |
2 |
2014 |
| Diagnostic Test |
procalcitonin |
2 |
2017 |
| Drug |
pyrazinamide |
2 |
1999 |
| Biological |
quadrivalent vlp vaccine |
2 |
2018 |
| Other |
quality-of-life assessment |
2 |
2013 |
| Other |
questionnaire administration |
2 |
2013 |
| Drug |
relebactam |
2 |
2015 |
| Drug |
relebactam 125 mg |
2 |
2012 |
| Drug |
relebactam 250 mg |
2 |
2012 |
| Drug |
rifapentine |
2 |
1999 |
| Drug |
rifaximin |
2 |
2018 |
| Drug |
rilpivirine 25 mg |
2 |
2012 |
| Drug |
rpv |
2 |
2014 |
| Procedure |
saliva |
2 |
2012 |
| Drug |
saquinavir |
2 |
1999 |
| Drug |
ser-109 |
2 |
2017 |
| Drug |
seraprevir |
2 |
2019 |
| Drug |
simeprevir |
2 |
2014 |
| Drug |
single-dose iv oritavancin diphosphate |
2 |
2010 |
| Behavioral |
smoking cessation |
2 |
2018 |
| Drug |
sodium fusidate |
2 |
2015 |
| Biological |
split, inactivated, trivalent influenza vaccine |
2 |
2006 |
| Device |
standard of care dressing |
2 |
2010 |
| Other |
standard wound dressing |
2 |
2013 |
| Biological |
strain of quadrivalent vlp vaccine |
2 |
2016 |
| Procedure |
supplemental perioperative oxygen |
2 |
2013 |
| Drug |
taf |
2 |
2016 |
| Drug |
tazobactam 0.5 g) |
2 |
2016 |
| placebo |
tdf placebo |
2 |
2012 |
| Dietary Supplement |
tea catechin extracts |
2 |
2009 |
| Drug |
tedizolid |
2 |
2015 |
| Drug |
teicoplanin |
2 |
2013 |
| Diagnostic Test |
telehealth |
2 |
2020 |
| Drug |
tenofovir df |
2 |
2012 |
| Drug |
tenofovir disoproxil fumarate (tdf) |
2 |
2007 |
| Drug |
tenofovir disoproxil fumarate/emtricitabine (tdf/ftc fdc) |
2 |
2016 |
| Drug |
thymopentin |
2 |
1999 |
| Drug |
topical pexiganan cream 0.8% |
2 |
2012 |
| placebo |
topical placebo cream |
2 |
2012 |
| Drug |
tr-701 fa |
2 |
2011 |
| Drug |
treatment interruption |
2 |
2015 |
| Drug |
trimethoprim (oral) |
2 |
2012 |
| Combination Product |
triple therapy |
2 |
2019 |
| Drug |
truvada |
2 |
2009 |
| Other |
ultrasound |
2 |
2012 |
| Drug |
vabomere |
2 |
2016 |
| Biological |
vaccine |
2 |
2017 |
| Drug |
vancomycin oral |
2 |
2019 |
| Drug |
vancomycin/antistaphylococcal penicillin |
2 |
2004 |
| Drug |
vancomycin/aztreonam |
2 |
2017 |
| Drug |
vicryl |
2 |
2009 |
| Dietary Supplement |
vitamin e |
2 |
2019 |
| Drug |
vorinostat |
2 |
2017 |
| Drug |
- aztreonam |
1 |
2011 |
| Drug |
- metronidazole |
1 |
2007 |
| Drug |
“raltegravir” |
1 |
2015 |
| Drug |
“raltegravir”/“zidovudine” |
1 |
2015 |
| Drug |
“zidovudine” |
1 |
2015 |
| Drug |
) tazobactam sodium |
1 |
2006 |
| Other |
< 10 days of antibiotics |
1 |
2017 |
| Drug |
0.1% octenidine with 30% 1-propanol |
1 |
2007 |
| Drug |
0.1% octenidine with 30% 1-propanol/45% 2-propanol |
1 |
2007 |
| Drug |
0.3% gatifloxacin |
1 |
2010 |
| Drug |
0.3% gatifloxacin/1.0% prednisolone acetate association |
1 |
2010 |
| Biological |
0.9% normal saline |
1 |
2008 |
| Other |
1-fermented dairy product containing the probiotic lactobacillus casei dn-114 001 (actimelâ®) |
1 |
2010 |
| Other |
1-step tuberculin skin test (tst) |
1 |
2009 |
| Other |
1-step tuberculin skin test (tst)/blood sampling |
1 |
2009 |
| Drug |
1% eye drops) |
1 |
2016 |
| Drug |
1.0% prednisolone acetate |
1 |
2010 |
| Drug |
1.0% prednisolone acetate association |
1 |
2010 |
| Drug |
10-day concomitant therapy |
1 |
2008 |
| Drug |
10-day sequential therapy |
1 |
2013 |
| Drug |
10-day sequential treatment |
1 |
2008 |
| Drug |
10 mg |
1 |
2014 |
| Drug |
10%povidone-iodine |
1 |
2018 |
| Drug |
10%povidone-iodine / coated suture |
1 |
2018 |
| Drug |
10%povidone-iodine / non-coated suture |
1 |
2018 |
| Drug |
100 mg) fdc |
1 |
2017 |
| Biological |
100 necator americanus l3 larvae |
1 |
2017 |
| Drug |
10d al quadruple therapy |
1 |
2018 |
| Drug |
10d tl quadruple therapy |
1 |
2018 |
| Drug |
1200 mg rifamycin sv dosage |
1 |
2018 |
| Drug |
12h |
1 |
2018 |
| Biological |
13-valent pneumococcal conjugate vaccine |
1 |
2009 |
| Biological |
13-valent pneumococcal conjugate vaccine (13vpnc) |
1 |
2009 |
| Biological |
13-valent pneumococcal polysaccharide conjugate vaccine |
1 |
2019 |
| Biological |
13-valent pneumococcal polysaccharide conjugate vaccine(crm197,tt) |
1 |
2019 |
| Drug |
14-day hybrid treatment |
1 |
2010 |
| Drug |
14-day sequential treatment |
1 |
2010 |
| Other |
14 days course of antibiotic treatment |
1 |
2014 |
| Biological |
15 âµg |
1 |
2016 |
| Biological |
15 âµg/strain of quadrivalent vlp vaccine |
1 |
2016 |
| Biological |
15 âµg/strain of the licensed quadrivalent vaccine |
1 |
2016 |
| Drug |
15 mg |
1 |
2014 |
| Biological |
150 necator americanus l3 larvae |
1 |
2017 |
| Drug |
160 mg trimethoprim |
1 |
1999 |
| Drug |
160 mg trimethoprim/800 mg sulfamethoxazole |
1 |
1999 |
| Biological |
18 |
1 |
2018 |
| placebo |
18 placebo |
1 |
2016 |
| Biological |
18 vaccine |
1 |
2016 |
| Biological |
18 vlp as04 |
1 |
2005 |
| Other |
18f-fdg pet scans |
1 |
2016 |
| Other |
2-non fermented dairy product (control) |
1 |
2010 |
| Drug |
2 antibiotics |
1 |
2015 |
| Drug |
2 dose |
1 |
2018 |
| Drug |
2 nrtis |
1 |
2016 |
| Drug |
2 nrtis/an ini, nnrti,/pi |
1 |
2016 |
| Drug |
2% alcoholic chlorhexidine |
1 |
2016 |
| Drug |
2% alcoholic chlorhexidine skin prep (skin prep) |
1 |
2019 |
| Drug |
2% chlorhexidine |
1 |
2018 |
| Drug |
2% chlorhexidine / coated suture |
1 |
2018 |
| Drug |
2% chlorhexidine / non-coated suture |
1 |
2018 |
| Device |
2% chlorhexidine gluconate (chg) cloth |
1 |
2015 |
| Drug |
2% chlorhexidine gluconate (chg) impregnated cloths |
1 |
2007 |
| Drug |
2% chlorhexidine gluconate impregnated cloth |
1 |
2005 |
| Drug |
2% chlorohexidine gluconate chin to toe |
1 |
2015 |
| Drug |
2% chlorohexidine gluconate standard of care |
1 |
2015 |
| Biological |
20 micrograms dose h5 vlp |
1 |
2010 |
| Drug |
200 mg eidd-2801 |
1 |
2020 |
| Biological |
2007 formulation) |
1 |
2006 |
| Biological |
23-valent pneumococcal polysaccharide vaccine (23vps) |
1 |
2009 |
| Drug |
24h |
1 |
2018 |
| Drug |
250ml hes 6% |
1 |
2012 |
| Other |
28 days of antibiotics |
1 |
2017 |
| Combination Product |
2nrtis |
1 |
2017 |
| Biological |
2x 50 l3 larvae infection |
1 |
2018 |
| Drug |
3 antibiotics |
1 |
2015 |
| Biological |
30 micrograms dose h5 vlp |
1 |
2010 |
| Other |
30% inhaled oxygen via nasal cannula |
1 |
2008 |
| Combination Product |
3hp |
1 |
2017 |
| Combination Product |
3hp/dtg /2nrtis |
1 |
2017 |
| Drug |
3m skin |
1 |
2011 |
| Drug |
3m skin/nasal antiseptic |
1 |
2011 |
| Device |
3mâ„¢ tegadermâ„¢ advanced iv |
1 |
2012 |
| Device |
3mâ„¢ tegadermâ„¢ chg iv |
1 |
2012 |
| Device |
3mâ„¢ tegadermâ„¢ chg iv/3mâ„¢ tegadermâ„¢ advanced iv |
1 |
2012 |
| Drug |
3tc) |
1 |
2012 |
| Biological |
3x 50 l3 larvae immunisation with albendazole treatment |
1 |
2018 |
| placebo |
3x placebo immunisation with albendazole treatment |
1 |
2018 |
| Drug |
4 |
1 |
2009 |
| Drug |
4% chlorhexidine gluconate soap-like solution |
1 |
2018 |
| Drug |
4% chlorhexidine gluconate vaginal scrub |
1 |
2018 |
| Drug |
4% chlorhexidine liquid soap |
1 |
2008 |
| Drug |
400 mg rifamycin sv dosage |
1 |
2018 |
| Biological |
45 micrograms dose h5 vlp |
1 |
2010 |
| Biological |
45 micrograms non-adjuvanted h5 vlp |
1 |
2010 |
| Drug |
45% 2-propanol |
1 |
2007 |
| Drug |
5 |
1 |
2005 |
| Drug |
5 gel |
1 |
2003 |
| Biological |
50 necator americanus l3 larvae |
1 |
2017 |
| Drug |
500 mg |
1 |
2014 |
| Drug |
6 mg |
1 |
2014 |
| Biological |
60 âµg |
1 |
2016 |
| Biological |
60 âµg/strain of quadrivalent vlp vaccine |
1 |
2016 |
| Other |
68ga-citrate |
1 |
2016 |
| Other |
68ga-citrate/18f-fdg pet scans |
1 |
2016 |
| Drug |
7-day quadruple therapy |
1 |
2013 |
| Drug |
7-day standard triple therapy |
1 |
2013 |
| Biological |
7-valent pneumococcal conjugated vaccine |
1 |
2013 |
| Other |
7 days course of antibiotic treatment |
1 |
2014 |
| Device |
70% isopropyl alcohol embedded caps |
1 |
2015 |
| Drug |
74% ethanol with 10% 2-propanol |
1 |
2007 |
| Other |
80% inhaled oxygen via non-rebreather mask |
1 |
2008 |
| Drug |
800 mg rifamycin sv dosage |
1 |
2018 |
| Drug |
800 mg sulfamethoxazole |
1 |
1999 |
| Drug |
9 mg |
1 |
2014 |
| Drug |
9% nacl 500ml |
1 |
2012 |
| Biological |
9vhpv vaccine |
1 |
2019 |
| Drug |
a-60444 |
1 |
2005 |
| Behavioral |
a strategy based on pct guided ab therapy |
1 |
2006 |
| Other |
a/current standard of care alone |
1 |
2015 |
| Biological |
a/h5n1 inactivated, split-virion influenza vaccine |
1 |
2007 |
| Biological |
a/h5n1 inactivated, split-virion influenza vaccine/adjuvant |
1 |
2007 |
| Biological |
a/h5n1 inactivated, split-virion pandemic influenza vaccine |
1 |
2007 |
| Drug |
aai101 combination |
1 |
2018 |
| Drug |
ab103 0.25 mg |
1 |
2011 |
| Drug |
ab103 0.25 mg/kg |
1 |
2011 |
| Drug |
abacavir (abc) |
1 |
2007 |
| Drug |
abacavir (abc)/lamivudine (3tc) / atazanavir (atv) |
1 |
2007 |
| Drug |
abacavir (abc)/lamivudine (3tc) / atazanavir (atv) / ritonavir (/r) |
1 |
2007 |
| Drug |
abacavir sulfate, lamivudine |
1 |
2001 |
| Drug |
abacavir sulfate, lamivudine/zidovudine |
1 |
2001 |
| Drug |
abacavir/lamivudine (abc/3tc)/tenofovir/emtricitabine (tdf/ftc) |
1 |
2012 |
| Drug |
abacavir/lamivudine/efavirenz |
1 |
2007 |
| Other |
abbreviation of treatment duration |
1 |
2015 |
| Drug |
abc fdc |
1 |
2015 |
| Drug |
abc/3tc |
1 |
2014 |
| Procedure |
abdominal closure bundle |
1 |
2018 |
| Procedure |
abdominal wall reconstruction |
1 |
2018 |
| Other |
abhs use |
1 |
2009 |
| Drug |
abi-1968 |
1 |
2017 |
| Device |
abs deployed |
1 |
2015 |
| Device |
abs deployed/active |
1 |
2015 |
| Device |
abs deployed/not active |
1 |
2015 |
| Procedure |
absorbable suture group |
1 |
2012 |
| Drug |
abt-450/ritonavir, abt-267 |
1 |
2012 |
| Drug |
abt-493 coformulated with abt-530 |
1 |
2016 |
| Drug |
abv (trizivir) |
1 |
2009 |
| Procedure |
access to an antibiotic decision support system |
1 |
2005 |
| Biological |
acellular pertussis vaccine adsorbed |
1 |
2001 |
| Drug |
acetylsalicylic acid (aspirin, baye4465) |
1 |
2011 |
| Drug |
activated t-lymphocytes |
1 |
2019 |
| Device |
active |
1 |
2015 |
| Biological |
active comparator hepatitis b vaccine |
1 |
2010 |
| Biological |
active comparator recombinant hepatitis b vaccine. |
1 |
2010 |
| Drug |
active control |
1 |
2019 |
| Device |
active control, vitamin c dosing into water |
1 |
2015 |
| Device |
active household uv water treatment device |
1 |
2020 |
| Procedure |
active voiding trial |
1 |
2016 |
| Drug |
acx-362e |
1 |
2020 |
| Biological |
ad26.hpv16 |
1 |
2018 |
| Biological |
ad26.hpv18 |
1 |
2018 |
| Biological |
adch3nsmut1 |
1 |
2014 |
| Drug |
adefovir dipivoxil |
1 |
1999 |
| placebo |
adefovir dipivoxil placebo |
1 |
1999 |
| Biological |
adenovirus infection |
1 |
2008 |
| Behavioral |
adherence report |
1 |
2009 |
| Other |
adherence to hand hygiene |
1 |
2020 |
| Biological |
adjuvant |
1 |
2007 |
| Procedure |
adjuvant therapy |
1 |
2006 |
| Biological |
adjuvanted high dose of quadrivalent vlp vaccine |
1 |
2014 |
| Biological |
adjuvanted low dose of quadrivalent vlp vaccine |
1 |
2014 |
| Other |
admission to a novel hospital ward |
1 |
2007 |
| Biological |
adv |
1 |
2018 |
| Biological |
adv specific t cells |
1 |
2009 |
| Drug |
aerosolized vancomycin |
1 |
2006 |
| Drug |
aerosolized vancomycin/gentamicin |
1 |
2006 |
| Drug |
afabicin |
1 |
2018 |
| Drug |
afn-12520000 |
1 |
2012 |
| Biological |
ags-v |
1 |
2019 |
| Biological |
ags-v/vaccine |
1 |
2019 |
| Behavioral |
aids 101 workshop |
1 |
2006 |
| Device |
air barrier system |
1 |
2012 |
| Drug |
albendazole 400mg |
1 |
2011 |
| Drug |
albendazole vs. |
1 |
2005 |
| Drug |
albendazole vs./albendazole/ivermectin treatment |
1 |
2005 |
| Drug |
albendazole, 2 x 400mg |
1 |
2011 |
| Drug |
alcohol |
1 |
2009 |
| Other |
alcohol-based hand rub (abhr) |
1 |
2009 |
| placebo |
alcohol placebo |
1 |
2009 |
| Diagnostic Test |
alert |
1 |
2018 |
| Device |
alexis o-ring wound retractor |
1 |
2015 |
| Device |
alexis o retractor |
1 |
2016 |
| Device |
algorithm for uti |
1 |
2016 |
| Biological |
alhydrogel hookworm vaccine |
1 |
2005 |
| Biological |
alhydrogelâ® adjuvant |
1 |
2019 |
| Drug |
alinia (nitazoxanide) |
1 |
2006 |
| Drug |
alirocumab |
1 |
2017 |
| Behavioral |
all babies are equal initiative (conditional cash transfer program) |
1 |
2019 |
| Biological |
allogeneic bk-specific cytotoxic t-lymphocytes |
1 |
2015 |
| Biological |
allogeneic cytomegalovirus-specific cytotoxic t lymphocytes |
1 |
2014 |
| Procedure |
allogeneic lymphocyte transfer |
1 |
1999 |
| Device |
allograft group |
1 |
2017 |
| Biological |
alteplase (recombinant t-pa) |
1 |
2018 |
| Biological |
alx-0171 |
1 |
2014 |
| Biological |
alx-0171 3.0 mg |
1 |
2016 |
| Biological |
alx-0171 3.0 mg/kg |
1 |
2016 |
| Biological |
alx-0171 6.0 mg |
1 |
2016 |
| Biological |
alx-0171 6.0 mg/kg |
1 |
2016 |
| Biological |
alx-0171 9.0 mg |
1 |
2016 |
| Biological |
alx-0171 9.0 mg/kg |
1 |
2016 |
| Device |
amd picasso |
1 |
2018 |
| Drug |
amikacin sulfate |
1 |
1999 |
| Drug |
aminolaevulinic acid photodynamic therapy |
1 |
2014 |
| Drug |
amitriptyline hydrochloride |
1 |
1999 |
| Procedure |
amniocentesis |
1 |
2006 |
| Drug |
amoxicillin-clavulanic acid |
1 |
2019 |
| Drug |
amoxicillin / clavulanic acid |
1 |
2020 |
| Drug |
amoxicillin 1.5 gr |
1 |
2015 |
| Drug |
amoxicillin 1gr |
1 |
2015 |
| Drug |
amoxicillin clavulanate |
1 |
2018 |
| Drug |
amoxicillin oral tablet |
1 |
2017 |
| Drug |
amoxicillin trihydrate |
1 |
1999 |
| Drug |
amoxicillin/clavulanate placebo |
1 |
2010 |
| Drug |
amoxicillin/clavulanate potassium 1gm |
1 |
2006 |
| Drug |
amoxicillin/clavulanic acid |
1 |
2008 |
| Drug |
amoxicillin/clavulunate potassium |
1 |
2011 |
| Drug |
amoxicilline |
1 |
2009 |
| Drug |
amoxicilline/clavulanic |
1 |
2009 |
| Drug |
amphotericin b liposomal (ambisome) |
1 |
2009 |
| Drug |
ampicillin |
1 |
2009 |
| Drug |
ampicillin sodium |
1 |
1999 |
| Drug |
ampicillin/sulbactam |
1 |
2009 |
| Drug |
an ini, nnrti, |
1 |
2016 |
| Drug |
an3365 |
1 |
2009 |
| Drug |
ana598 |
1 |
2009 |
| Drug |
anaferon for children |
1 |
2014 |
| Drug |
anaferon for children (liquid dosage form) |
1 |
2017 |
| Drug |
anakinra |
1 |
2020 |
| Drug |
anidulafungin |
1 |
2009 |
| Drug |
annona muricata |
1 |
2014 |
| Other |
anti-infective agents |
1 |
2013 |
| Biological |
anti-mycoplasma hominis antibodies |
1 |
2015 |
| Drug |
anti-pseudomonas igy gargle |
1 |
2008 |
| Drug |
anti-schistosoma regimens |
1 |
2008 |
| Drug |
antibiotic comparator |
1 |
2014 |
| Biological |
antibiotic concentration in pleural fluid |
1 |
2020 |
| Drug |
antibiotic durations |
1 |
2017 |
| Other |
antibiotic education for children in an emergency care unit |
1 |
2009 |
| Device |
antibiotic local prophylaxis with medicated calcium sulfate beads |
1 |
2019 |
| Drug |
antibiotic of investigator’s choice |
1 |
2013 |
| Behavioral |
antibiotic prescription feedback |
1 |
2012 |
| Drug |
antibiotic prophylaxis |
1 |
2015 |
| Behavioral |
antibiotic stewardship program |
1 |
2017 |
| Procedure |
antibiotic therapy |
1 |
2019 |
| Other |
antimicrobial hand towel |
1 |
2015 |
| Device |
antimicrobial impregnated catheter (5593) |
1 |
2007 |
| Radiation |
antimicrobial photodynamic therapy |
1 |
2017 |
| Drug |
antimicrobial solution |
1 |
2012 |
| Behavioral |
antimicrobial stewardship |
1 |
2019 |
| Device |
antimicrobial synthetic bone graft |
1 |
2019 |
| Dietary Supplement |
antioxidants |
1 |
2008 |
| Drug |
antiretroviral therapy (art) (regimen will vary within countries |
1 |
2015 |
| Drug |
antiretroviral therapy (art) (regimen will vary within countries/by patient) |
1 |
2015 |
| Device |
antiseptic-coated central venous catheters |
1 |
2006 |
| Drug |
antiseptic bundle |
1 |
2014 |
| Biological |
antiseptic substantivity |
1 |
2011 |
| Device |
apheresis machine |
1 |
2008 |
| Procedure |
application of a contralateral drainage (penrose â® device) |
1 |
2013 |
| Combination Product |
applicator |
1 |
2019 |
| Other |
aquacel silver |
1 |
2018 |
| Drug |
ar-301 |
1 |
2018 |
| Dietary Supplement |
arabinoxylan rice bran |
1 |
2016 |
| Drug |
arbidol |
1 |
2020 |
| Drug |
arctuvan |
1 |
2017 |
| Device |
aries bordetella assay |
1 |
2016 |
| Drug |
arm 2: decolonization |
1 |
2014 |
| Drug |
arm a: poly-iclc |
1 |
2014 |
| Drug |
arm b: normal saline |
1 |
2014 |
| Drug |
art at 24 weeks |
1 |
2016 |
| Drug |
art initiation at time of hiv diagnosis |
1 |
2016 |
| Drug |
artemether-lumefantrine 20 mg-120 mg oral tablet |
1 |
2020 |
| Drug |
artemether lumefantrine |
1 |
2014 |
| Drug |
artemic |
1 |
2020 |
| Procedure |
articulating spacer |
1 |
2011 |
| Drug |
arv regimen |
1 |
2005 |
| Biological |
as02a vaccine |
1 |
2005 |
| Behavioral |
ask me 3 |
1 |
2014 |
| Drug |
aspirin |
1 |
2015 |
| Drug |
at-777 |
1 |
2020 |
| Drug |
atazanavir (atv) |
1 |
2007 |
| Drug |
atovaquone |
1 |
1999 |
| Drug |
atovaquone proguanil |
1 |
2018 |
| Drug |
atriplaâ® |
1 |
2010 |
| Other |
audit/feedback |
1 |
2017 |
| Drug |
aurograb |
1 |
2005 |
| Biological |
autologous dendritic cells with no mrna transfection |
1 |
2009 |
| Biological |
autologous fecal microbiota therapy |
1 |
2014 |
| Behavioral |
automated reminder |
1 |
2015 |
| Behavioral |
automated reminder/script |
1 |
2015 |
| Drug |
avibactam (avi) |
1 |
2012 |
| Drug |
azasite (azithromycin ophthalmic solution) |
1 |
2007 |
| Drug |
azasite eye drops |
1 |
2007 |
| Drug |
azithromycin 1 gram |
1 |
2012 |
| Drug |
azithromycin 250 mg |
1 |
2017 |
| Drug |
azithromycin 500 mg oral tablet x 4 |
1 |
2019 |
| Drug |
azithromycin/placebo |
1 |
2013 |
| Drug |
azithromycin/standard of care |
1 |
2010 |
| Drug |
azt/3tc/abv (trizivir) |
1 |
2009 |
| Drug |
aztreonam (atm) |
1 |
2012 |
| Drug |
aztreonam for inhalation (ai) |
1 |
2010 |
| Drug |
b/current standard of care/zmapp |
1 |
2015 |
| Combination Product |
bacillus clausii |
1 |
2018 |
| Biological |
bacterial culture of the prepared skin’s areas |
1 |
2011 |
| Other |
bacterial culture of the prepared skin’s areas with two antiseptics |
1 |
2013 |
| Other |
bacterial culture of the prepared skin’s areas with two antiseptics/two controls |
1 |
2013 |
| Drug |
bacterial lysates |
1 |
2008 |
| Procedure |
bacterial ulcer control |
1 |
2015 |
| Procedure |
bacterial ulcer cross-linking |
1 |
2015 |
| Biological |
bacteriological analyses on clinical samples performed with swabs |
1 |
2017 |
| Device |
bactiguard infection protection (bip) cathter. |
1 |
2010 |
| Drug |
bactrobanâ® nasal ong |
1 |
2019 |
| Other |
bal fluid sampling |
1 |
2016 |
| Dietary Supplement |
bb12 |
1 |
2008 |
| Drug |
bc-3781 |
1 |
2010 |
| Other |
bca method for assessing environmental cleanliness |
1 |
2019 |
| Biological |
bcg |
1 |
2013 |
| Drug |
bcx4430 |
1 |
2014 |
| Biological |
begrivacâ® |
1 |
2009 |
| Behavioral |
behavior change communication to promote hygiene behavior |
1 |
2019 |
| Other |
behavioral counseling |
1 |
2007 |
| Drug |
benzoyl peroxide solution |
1 |
2014 |
| Drug |
benzoyl peroxide solution/chlorhexidine scrub |
1 |
2014 |
| Drug |
benztropine mesylate |
1 |
1999 |
| Drug |
beta-lactam |
1 |
2006 |
| Behavioral |
betadine douches |
1 |
2018 |
| Procedure |
betadine lavage |
1 |
2010 |
| Drug |
bifidobacterium animalis oral product |
1 |
2017 |
| Dietary Supplement |
bifidobacterium infantis |
1 |
2018 |
| Drug |
biktarvy |
1 |
2018 |
| Diagnostic Test |
biofire film array gastrointestinal panel |
1 |
2018 |
| Other |
biological samples collection of blood |
1 |
2016 |
| Other |
biological samples collection of blood/feces |
1 |
2016 |
| Other |
biomarker- elispot test |
1 |
2015 |
| Device |
bionecteur |
1 |
2014 |
| Procedure |
biopsy(ies) during high resolution anoscopy |
1 |
2014 |
| Drug |
bismuth |
1 |
2015 |
| Biological |
bkv specific t cells |
1 |
2018 |
| Other |
bleach |
1 |
2012 |
| Other |
bleach bath (dilute) |
1 |
2013 |
| Procedure |
bleach baths (dilute) |
1 |
2007 |
| Other |
bleach/uv-c light |
1 |
2012 |
| Other |
blood |
1 |
2020 |
| Other |
blood culture |
1 |
2010 |
| Diagnostic Test |
blood cultures |
1 |
2018 |
| Other |
blood stage malaria challenge infection, p. falciparum 3d7 |
1 |
2018 |
| Procedure |
blood testing |
1 |
1999 |
| Procedure |
blood transfusion |
1 |
1999 |
| Drug |
bms-650032 |
1 |
2010 |
| Drug |
bms-790052 |
1 |
2010 |
| Biological |
bms-914143 (peginterferon lambda-1a) |
1 |
2012 |
| Drug |
bms-955176 |
1 |
2013 |
| Biological |
bnt162a1 |
1 |
2020 |
| Biological |
bnt162b1 |
1 |
2020 |
| Biological |
bnt162b2 |
1 |
2020 |
| Biological |
bnt162c2 |
1 |
2020 |
| Drug |
boceprevir, peg-interferon alfa 2b |
1 |
2011 |
| Drug |
boceprevir, peg-interferon alfa 2b/ribavirin |
1 |
2011 |
| Device |
bone allograft |
1 |
2017 |
| Device |
bone auto |
1 |
2017 |
| Device |
bone auto/allograft group |
1 |
2017 |
| Procedure |
bone marrow transplant |
1 |
1999 |
| Other |
booster sessions |
1 |
2016 |
| Drug |
boswellia leaf extract |
1 |
2014 |
| Procedure |
bowel preparation |
1 |
2016 |
| Diagnostic Test |
breath volatile organic compounds under chemotherapy |
1 |
2018 |
| Other |
brief intervention |
1 |
2013 |
| Other |
brief intervention/parent leaflet |
1 |
2013 |
| Drug |
brilacidin |
1 |
2014 |
| Drug |
broad-spectrum antibiotics |
1 |
2019 |
| Drug |
bromhexine hydrochloride |
1 |
2020 |
| Drug |
btz-043 |
1 |
2018 |
| Other |
buckwheat honey |
1 |
2010 |
| Drug |
buffergel |
1 |
2003 |
| Other |
bundled l&d infection prevention interventions |
1 |
2019 |
| Drug |
by patient) |
1 |
2015 |
| Drug |
c |
1 |
2016 |
| Biological |
c-reactive protein |
1 |
2012 |
| Biological |
c-reactive protein/procalcitonin dosages |
1 |
2012 |
| Drug |
c 500 mg |
1 |
2011 |
| Drug |
cabotegravir - injectable suspension (cab la) |
1 |
2016 |
| Drug |
cabotegravir (cab) tablet |
1 |
2016 |
| Drug |
cabotegravir injection 3 ml (200 mg |
1 |
2015 |
| Drug |
cabotegravir injection 3 ml (200 mg/ml) im given once on day 1. |
1 |
2015 |
| Drug |
cabotegravir tablet 30 mg once daily for 28 days. |
1 |
2015 |
| Drug |
cadazolid |
1 |
2014 |
| Drug |
caffeine |
1 |
2011 |
| Drug |
camostat mesilate |
1 |
2020 |
| Drug |
canephronâ® n |
1 |
2011 |
| Drug |
carboplatin |
1 |
2006 |
| Behavioral |
care services |
1 |
2007 |
| Diagnostic Test |
care with c-reactive protein assay in micro method |
1 |
2018 |
| Other |
carrageenan-based gel |
1 |
2015 |
| Other |
cash |
1 |
2017 |
| Other |
cash transfer |
1 |
2017 |
| Drug |
catechin extracts (health food) |
1 |
2005 |
| Dietary Supplement |
caterpillar cereal |
1 |
2011 |
| Other |
catheter clamping only |
1 |
2020 |
| Drug |
catheter insertion with povidone iodine |
1 |
2017 |
| Device |
catheter replacement |
1 |
2017 |
| Drug |
cb-183,315 |
1 |
2010 |
| Drug |
cd4 antigens |
1 |
1999 |
| Biological |
cd45ra-depleted peripheral blood mononuclear cells |
1 |
2016 |
| Drug |
cefazolin in combination with either tobramycin |
1 |
2016 |
| Drug |
cefazolin in combination with either tobramycin/gentamicin |
1 |
2016 |
| Other |
cefazolin irrigation |
1 |
2012 |
| Drug |
cefdinir |
1 |
2005 |
| Drug |
cefepime/aai101 combination |
1 |
2018 |
| Drug |
cefepime/vnrx-5133 (taniborbactam) |
1 |
2019 |
| Drug |
cefoperazone sodium 1:1) pfizer ltd. |
1 |
2006 |
| Drug |
cefotaxime injection |
1 |
2019 |
| Drug |
cefotaxime/ceftriaxone |
1 |
2019 |
| Drug |
ceftaroline fosamil/nxl104 (q12h) |
1 |
2011 |
| Drug |
ceftaroline fosamil/nxl104 (q8h) |
1 |
2011 |
| Drug |
ceftazidime-avibactam |
1 |
2012 |
| Drug |
ceftazidime/nxl104 / metronidazole |
1 |
2008 |
| Drug |
ceftolozane/tazobactam |
1 |
2019 |
| Drug |
ceftolozane/tazobactam 1000/500 mg |
1 |
2014 |
| Drug |
ceftolozane/tazobactam 12/6 mg/kg |
1 |
2014 |
| Drug |
ceftolozane/tazobactam 18/9 mg/kg |
1 |
2014 |
| Drug |
ceftolozane/tazobactam 20/10 mg/kg |
1 |
2014 |
| Drug |
ceftolozane/tazobactam 30/15 mg/kg |
1 |
2014 |
| Drug |
ceftriaxone / metronidazole |
1 |
2008 |
| Drug |
ceftriaxone 2g |
1 |
2018 |
| Drug |
ceftriaxone 2g/ 12h |
1 |
2018 |
| Drug |
ceftriaxone 4g |
1 |
2018 |
| Drug |
ceftriaxone 4g/ 24h |
1 |
2018 |
| Drug |
ceftriaxone intravenous |
1 |
2014 |
| Drug |
ceftriaxone sodium / metronidazole |
1 |
2005 |
| Drug |
ceftriaxone sodium/sulbactam sodium for injection |
1 |
2019 |
| Drug |
ceftriaxone/metronidazole |
1 |
2005 |
| Drug |
cefuroxime 1.5 g intravenous |
1 |
2015 |
| Drug |
cefuroxime/metronidazole |
1 |
2008 |
| Other |
cell therapy |
1 |
2011 |
| Procedure |
cement with erytromycin |
1 |
2012 |
| Procedure |
cement with erytromycin/colistin. |
1 |
2012 |
| Procedure |
cement without antibiotic. |
1 |
2012 |
| Drug |
central nervous system (cns) prophylaxis |
1 |
2007 |
| Device |
central venous catheter |
1 |
2007 |
| Device |
centricyte 1000 |
1 |
2020 |
| Drug |
cephalexin/clindamycin/linezolid |
1 |
2011 |
| Drug |
cephalozin |
1 |
2014 |
| Other |
ceramic water filter |
1 |
2012 |
| Biological |
chadv63.hivconsv |
1 |
2014 |
| Drug |
chemotherapy |
1 |
2019 |
| Procedure |
chest tube drainage |
1 |
2020 |
| Behavioral |
chip |
1 |
2019 |
| Device |
chlorhexidine-impregnated disk |
1 |
2018 |
| Other |
chlorhexidine bathing |
1 |
2014 |
| Drug |
chlorhexidine gluconate (chg) |
1 |
2017 |
| placebo |
chlorhexidine gluconate (drug) vs placebo |
1 |
2006 |
| Drug |
chlorhexidine gluconate 2% wipe |
1 |
2018 |
| Procedure |
chlorhexidine gluconate skin cleanser |
1 |
2013 |
| Device |
chlorhexidine impregnated patch (biopatch) |
1 |
2011 |
| Biological |
chlorhexidine in isopropyl alcohol |
1 |
2011 |
| Drug |
chlorhexidine scrub |
1 |
2014 |
| Genetic |
chlorhexidine showers |
1 |
2007 |
| Drug |
chlorhexidine sol 4% |
1 |
2015 |
| Drug |
chlorhexidine, lifo-scrub sol 4%â®, 500ml, b. braun |
1 |
2019 |
| Drug |
chloroquine |
1 |
2014 |
| Dietary Supplement |
cholecalciferol |
1 |
2012 |
| Dietary Supplement |
cholecalciferol (vitamin d |
1 |
2010 |
| Dietary Supplement |
cholecalciferol (vitamin d/vigantol oil) |
1 |
2010 |
| Dietary Supplement |
cholecalciferol (vitamin d3) |
1 |
2010 |
| Behavioral |
chw tbi) program |
1 |
2018 |
| Drug |
cilastatin 500 mg |
1 |
2012 |
| Drug |
cimetidine |
1 |
1999 |
| Drug |
cipro ir (ciprofloxacin, bayq3939) |
1 |
2008 |
| Drug |
ciprofloxacin 750 mg oral |
1 |
2015 |
| Drug |
ciprofloxacin hydrochloride |
1 |
1999 |
| Drug |
ciprofloxacin/cefazolin //- metronidazole |
1 |
2007 |
| Procedure |
circumcision |
1 |
2015 |
| Drug |
cisplatin |
1 |
2019 |
| Drug |
clarithromycin 1000 mg |
1 |
2017 |
| Drug |
clarithromycin oral tablet |
1 |
2017 |
| Drug |
clarithromycin, amoxicillin, omeprazole |
1 |
2008 |
| Drug |
clarithromycin, metronidazole, amoxicillin ( |
1 |
2008 |
| Drug |
clarithromycin, metronidazole, amoxicillin (/omeprazole) |
1 |
2008 |
| Drug |
clarythromicin 500 mg |
1 |
2015 |
| Procedure |
classical parenteral antibiotic prophylaxis |
1 |
2019 |
| placebo |
clavulanate placebo |
1 |
2010 |
| Drug |
clavulanate potassium 1gm |
1 |
2006 |
| Drug |
clavulanic |
1 |
2009 |
| Drug |
clavulunate potassium |
1 |
2011 |
| Procedure |
clean patient preparation for cystoscopy |
1 |
2005 |
| Device |
click device |
1 |
2019 |
| Biological |
clindamycin/rifampicin dosages |
1 |
2016 |
| Behavioral |
clinical decision support (cds): accountable justifications |
1 |
2011 |
| Behavioral |
clinical decision support: accountable justification |
1 |
2011 |
| Other |
clinical pathway |
1 |
2016 |
| Drug |
clinsupv3 -soft gelatin capsule |
1 |
2012 |
| Drug |
clinsupv3er- extended release tablet |
1 |
2012 |
| Drug |
clopidogrel |
1 |
2015 |
| Procedure |
clorhexidine |
1 |
2012 |
| Device |
closed incision negative pressure therapy (cinpt) |
1 |
2017 |
| Biological |
clostridium difficile toxoid vaccine |
1 |
2008 |
| Biological |
clostridium difficile toxoid vaccine with adjuvant |
1 |
2008 |
| Drug |
cloxacillin |
1 |
2009 |
| Biological |
cmv-peptide-specific t cells |
1 |
2008 |
| Biological |
cmv-specific t-cells |
1 |
2019 |
| Biological |
cmv-tcr-t cells |
1 |
2019 |
| Biological |
cmv gb vaccine |
1 |
2005 |
| Drug |
cmv hyperimmune globulin |
1 |
2011 |
| Other |
cmv pcr |
1 |
2014 |
| Biological |
cmv specific adoptive t-cells |
1 |
2016 |
| Biological |
cmv specific t-cells |
1 |
2019 |
| Biological |
cmv/adv /ebv/bkv specific t cells |
1 |
2018 |
| Biological |
cmv/adv specific t cells |
1 |
2009 |
| Biological |
cmvpp65 specific t-cells |
1 |
2014 |
| Drug |
co-trimoxazole; tmp-smz |
1 |
2005 |
| Other |
coaching program |
1 |
2015 |
| Drug |
coated suture |
1 |
2018 |
| Drug |
coated vicryl |
1 |
2020 |
| Dietary Supplement |
cold-fx |
1 |
2005 |
| Dietary Supplement |
cold-fx natural health product |
1 |
2005 |
| Drug |
colistimethate sodium |
1 |
2018 |
| Drug |
colistimethate sodium (cms) |
1 |
2015 |
| Procedure |
colistin. |
1 |
2012 |
| Device |
collagen-gentamicin sponge |
1 |
2011 |
| Procedure |
collagen cross-linking |
1 |
2013 |
| Other |
collection of blood samples for pk testing |
1 |
2011 |
| Drug |
collection of fluid samples |
1 |
2018 |
| Other |
collection of nosocomial infections |
1 |
2016 |
| Procedure |
colonization swab samples |
1 |
2009 |
| Procedure |
colorectal surgery |
1 |
2015 |
| Drug |
combination of aztreonam - avibactam (atm-avi) |
1 |
2012 |
| Biological |
combined heptavalent pneumococcal conjugate vaccine |
1 |
2005 |
| Biological |
combined heptavalent pneumococcal conjugate vaccine/trivalent inactivated influenza vaccine |
1 |
2005 |
| Drug |
combivir |
1 |
2004 |
| placebo |
comfort bath cloths (placebo cloths) |
1 |
2007 |
| Behavioral |
communidades positivas (cpos) |
1 |
2008 |
| Other |
community based |
1 |
2008 |
| Behavioral |
community event |
1 |
2019 |
| Behavioral |
community health worker intervention |
1 |
2017 |
| Drug |
comparator : piperacillin sodium ( |
1 |
2006 |
| Drug |
comparator : piperacillin sodium (/) tazobactam sodium /duration of treatment : 8 weeks |
1 |
2006 |
| Drug |
comparator: ceftriaxone |
1 |
2005 |
| Drug |
comparator: ceftriaxone / metronidazole |
1 |
2005 |
| Drug |
comparator: ceftriaxone sodium / duration of treatment: 8 weeks |
1 |
2007 |
| Drug |
comparator: ceftriaxone sodium /duration of treatment: 14 days |
1 |
2007 |
| Biological |
comparator: hpv 16 l1 vaccine |
1 |
2006 |
| Drug |
comparator: metronidazole |
1 |
2007 |
| Drug |
comparator: metronidazole / duration of treatment: 8 weeks |
1 |
2007 |
| Drug |
comparator: micafungin sodium |
1 |
2008 |
| Drug |
comparator: piperacillin |
1 |
2005 |
| Drug |
comparator: piperacillin/tazobactam / duration of treatment - 24 weeks |
1 |
2005 |
| placebo |
comparator: placebo |
1 |
2006 |
| Drug |
comparator: ticarcillin |
1 |
2004 |
| Drug |
comparator: ticarcillin/clavulanate |
1 |
2004 |
| Drug |
comparator: vancomycin |
1 |
2008 |
| Procedure |
comparison of screening methods |
1 |
2013 |
| Other |
computerized decision support |
1 |
2017 |
| Other |
computerized decision support/audit/feedback |
1 |
2017 |
| Drug |
concentrated herbal extract granules tra |
1 |
2020 |
| Drug |
concomitant therapy |
1 |
2018 |
| Other |
conditional cash transfer condition |
1 |
2018 |
| Drug |
conjugated estrogen |
1 |
2020 |
| Drug |
conjugated estrogen vaginal cream |
1 |
2013 |
| Other |
consumption of heat-sterilized kombucha |
1 |
2019 |
| Other |
consumption of kombucha |
1 |
2019 |
| Other |
contact isolation |
1 |
2008 |
| Drug |
contezolid acefosamil |
1 |
2018 |
| Other |
continue triple arvs |
1 |
2010 |
| Drug |
continued standard of care with tenofovir in addition to emtricitabine |
1 |
2008 |
| Drug |
continued standard of care with tenofovir in addition to emtricitabine/lamivudine |
1 |
2008 |
| Other |
continuing antibiotic therapy |
1 |
2016 |
| Device |
continuous sternal block |
1 |
2008 |
| Device |
continuous topical triple-tube irrigation |
1 |
2013 |
| Device |
continuous topical triple-tube irrigation/suction |
1 |
2013 |
| Other |
control gel |
1 |
2015 |
| Behavioral |
control group audio jingles |
1 |
2019 |
| Device |
conveen uncoated |
1 |
2006 |
| Procedure |
conventional endodontic treatment |
1 |
2017 |
| Drug |
conventional glycemic |
1 |
2013 |
| Other |
conventional sterile dry wound dressing |
1 |
2013 |
| Other |
copper-alloy surfaced objects |
1 |
2012 |
| Other |
copper-alloy surfaced patient care objects |
1 |
2012 |
| Other |
copper impregnated maternity pads |
1 |
2017 |
| Other |
copper impregnated wound dressing |
1 |
2017 |
| Procedure |
cord blood sample |
1 |
2010 |
| Drug |
corticosteroids (prednisolone acetate 0.5% |
1 |
2016 |
| Drug |
corticosteroids (prednisolone acetate 0.5%/1% eye drops) |
1 |
2016 |
| Biological |
cp101 |
1 |
2018 |
| Biological |
cpg 10104 |
1 |
2017 |
| Drug |
cranberry |
1 |
2006 |
| Other |
cranberry-lingonberry juice |
1 |
2013 |
| Drug |
cranberry capsules |
1 |
2018 |
| Drug |
cranberry powder capsules |
1 |
2011 |
| Dietary Supplement |
cranberry type a pro anthocyandines |
1 |
2010 |
| Drug |
cravit-based sequential therapy |
1 |
2009 |
| Drug |
crv431 |
1 |
2018 |
| Drug |
csaac |
1 |
2018 |
| Drug |
csac |
1 |
2018 |
| Drug |
cse-1034 (ceftriaxone |
1 |
2018 |
| Drug |
cse-1034 (ceftriaxone / sulbactam / edta) |
1 |
2018 |
| Procedure |
csvf |
1 |
2020 |
| Diagnostic Test |
ct-scan |
1 |
2016 |
| Behavioral |
cultural adaptation of a patient-provider communication tool |
1 |
2020 |
| Procedure |
culture |
1 |
2006 |
| Other |
culture swabs, rodac plate cultures |
1 |
2010 |
| Other |
cups |
1 |
2017 |
| Other |
cups/cash |
1 |
2017 |
| Drug |
current standard of care |
1 |
2015 |
| Other |
current standard of care alone |
1 |
2015 |
| Drug |
current standard of care in kenya |
1 |
2007 |
| Behavioral |
current standard pd training |
1 |
2018 |
| Combination Product |
cutimed |
1 |
2018 |
| Drug |
cvt-e002 (cold-fx); a natural health product |
1 |
2005 |
| Drug |
cvt-e002 ginseng extract |
1 |
2005 |
| Drug |
cxa-101/ tazobactam/metronidazole |
1 |
2010 |
| Drug |
cxa-201/metronidazole |
1 |
2011 |
| Drug |
cycloplegic agents (cyclopentolate 1% eye drops) |
1 |
2016 |
| Drug |
cystoscopic fluid |
1 |
2017 |
| Drug |
cystoscopic fluid containing neosporin g. u. irrigant |
1 |
2017 |
| Drug |
cystoscopic fluid/placebo |
1 |
2017 |
| Procedure |
cystoscopy |
1 |
2017 |
| Procedure |
cytokine therapy |
1 |
2005 |
| Procedure |
cytology specimen collection procedure |
1 |
2016 |
| Drug |
cytotoxic t-lymphocytes |
1 |
2017 |
| Biological |
cytotoxic t lymphocytes |
1 |
2012 |
| Drug |
cytotoxic t lymphocytes (ctls). |
1 |
2013 |
| Dietary Supplement |
d mannose |
1 |
2013 |
| Drug |
d_plex |
1 |
2018 |
| Device |
dacc-coated post operative dressing |
1 |
2016 |
| Device |
dacc impregnated dressing |
1 |
2014 |
| Dietary Supplement |
daily multi micronutrient supplement |
1 |
2011 |
| Other |
daily review |
1 |
2010 |
| placebo |
dalbavancin-matching placebo |
1 |
2014 |
| Drug |
dalbavancin single dose |
1 |
2016 |
| Drug |
dalbavancin two dose |
1 |
2016 |
| Drug |
daptomycin 4 mg |
1 |
2008 |
| Drug |
daptomycin 4 mg/kg |
1 |
2008 |
| Drug |
daptomycin 6 mg |
1 |
2008 |
| Drug |
daptomycin 6 mg/kg |
1 |
2008 |
| Drug |
daptomycin 6mg |
1 |
2005 |
| Drug |
daptomycin 6mg/kg/day |
1 |
2005 |
| Drug |
daptomycin for injection |
1 |
2018 |
| Drug |
darunavir-cobicistat |
1 |
2016 |
| Drug |
darunavir; ritonavir; emtricitabine |
1 |
2009 |
| Drug |
darunavir; ritonavir; emtricitabine/tenofovir |
1 |
2009 |
| Drug |
das181 |
1 |
2019 |
| Drug |
das181 covid-19 |
1 |
2019 |
| Drug |
das181 ol |
1 |
2019 |
| Device |
dav132 |
1 |
2018 |
| Drug |
day |
1 |
2005 |
| Biological |
day 140 |
1 |
2018 |
| Dietary Supplement |
day) |
1 |
2014 |
| Drug |
dcvax-001 |
1 |
2010 |
| Drug |
debio 1450 |
1 |
2016 |
| Drug |
debio 1450 iv |
1 |
2015 |
| Drug |
debio 1450 oral |
1 |
2015 |
| placebo |
debio 1450 oral placebo |
1 |
2015 |
| Behavioral |
debunking misinformation through audio dramas |
1 |
2019 |
| Procedure |
delayed primary closure |
1 |
2015 |
| Other |
delegation form |
1 |
2010 |
| Biological |
dendritic cell vaccine |
1 |
2006 |
| Other |
depletion |
1 |
2005 |
| Device |
dermabond |
1 |
2016 |
| Combination Product |
descovy |
1 |
2019 |
| Combination Product |
descovy/dolutegravir |
1 |
2019 |
| Procedure |
device replacement(pocket capsule removal) |
1 |
2014 |
| Drug |
dexlansoprazole based triple therapy |
1 |
2015 |
| Drug |
dextrose 5% in water |
1 |
2010 |
| Other |
diagnosis |
1 |
2016 |
| Other |
diagnosis, treatment |
1 |
2009 |
| Other |
diagnosis, treatment/education |
1 |
2009 |
| Biological |
diagnostic performances of a combination of biomarkers |
1 |
2017 |
| Other |
dialogue tool |
1 |
2018 |
| Other |
diaper incentive |
1 |
2018 |
| Drug |
dicloxacillin |
1 |
2002 |
| Diagnostic Test |
differential (cbc) |
1 |
2018 |
| Drug |
dinitrochlorobenzene |
1 |
1999 |
| Biological |
diphtheria |
1 |
2001 |
| Biological |
diphtheria/tetanus toxoids/acellular pertussis vaccine adsorbed |
1 |
2001 |
| Drug |
dipyridamole |
1 |
2020 |
| Other |
discontinuation of prophylactic drugs i.e. co-trimoxazole, dapsone, fluconazole, itraconazole, azithromycin |
1 |
2011 |
| Other |
discontinue tmp |
1 |
2011 |
| Other |
discontinue tmp/smz prophylaxis |
1 |
2011 |
| Other |
discontinue triple arvs |
1 |
2010 |
| Other |
discontinuing antibiotic therapy |
1 |
2016 |
| Device |
disposable negative wound pressure device (pico) |
1 |
2018 |
| Behavioral |
distance learning package for general practitioners |
1 |
2006 |
| Behavioral |
distance learning package for practice assistants |
1 |
2006 |
| Behavioral |
distribution of local antibiotic guidelines |
1 |
2005 |
| Biological |
dna plasmid encoding interleukin-12 ino-9012 |
1 |
2016 |
| Drug |
dolutegravir 50 mg |
1 |
2017 |
| Drug |
dolutegravir/abacavir/lamivudine fdc |
1 |
2013 |
| Biological |
donor-derived cmvpp65-specific t cells |
1 |
2016 |
| Biological |
donor derived cytomegalovirus specific t lymphocytes |
1 |
2016 |
| Other |
donor milk |
1 |
2017 |
| Drug |
doripenum |
1 |
2005 |
| Biological |
dosage of the umbilical cord blood procalcitonin for diagnosing of ibnp |
1 |
2016 |
| Drug |
doxy |
1 |
2018 |
| Drug |
doxycycline 200 mg |
1 |
2015 |
| Drug |
doxycyline hyclate tablet |
1 |
2010 |
| Device |
dr. chip hpv genotyping ivd kit |
1 |
2020 |
| Procedure |
drainage |
1 |
2015 |
| Drug |
drug conversion to sirolimus |
1 |
2016 |
| Drug |
dtg 50 mg |
1 |
2014 |
| Drug |
dtg/3tc/abc fdc |
1 |
2015 |
| Drug |
dtg/rpv fdc |
1 |
2016 |
| Diagnostic Test |
dual-priming oligonucleotide-based multiplex (dpo)-pcr test |
1 |
2019 |
| Device |
dual focus with narrow band imaging |
1 |
2019 |
| Drug |
dual therapy |
1 |
2019 |
| Drug |
duloxetine 60 mg, qd |
1 |
2007 |
| Procedure |
duodenal biopsy |
1 |
2017 |
| Device |
duraderm |
1 |
2018 |
| Other |
duration of antibiotic treatment |
1 |
2013 |
| Drug |
duration of standard antibiotic therapy |
1 |
2019 |
| Drug |
duration of treatment - 24 weeks |
1 |
2005 |
| Drug |
duration of treatment: 8 weeks |
1 |
2007 |
| Drug |
e |
1 |
2016 |
| Biological |
e. coli 83972 |
1 |
2009 |
| Biological |
e. coli strain e1392-75-2a |
1 |
2015 |
| Biological |
e.coli bioconjugate vaccine |
1 |
2014 |
| Drug |
e/c/f/taf |
1 |
2016 |
| Drug |
ebr/gzr |
1 |
2017 |
| Drug |
ebr/gzr (50 mg/100 mg) fdc |
1 |
2017 |
| Biological |
ebv |
1 |
2018 |
| Drug |
echinacea |
1 |
2011 |
| Drug |
echinacea purpurea alcoholic extract |
1 |
2018 |
| Drug |
ecn-suspension |
1 |
2016 |
| Drug |
edp-514 |
1 |
2019 |
| Drug |
edta) |
1 |
2018 |
| Other |
education |
1 |
2009 |
| Behavioral |
educational intervention |
1 |
2006 |
| Behavioral |
educational intervention on antibiotic prescribing |
1 |
2010 |
| Behavioral |
educational intervention program |
1 |
2006 |
| Drug |
efavirenz 600 mg |
1 |
2012 |
| Drug |
efavirenz, emtricitabine, |
1 |
2009 |
| Drug |
efavirenz, emtricitabine,/tenofovir |
1 |
2009 |
| Drug |
efv |
1 |
2015 |
| Drug |
efv 600 mg |
1 |
2014 |
| Drug |
efv only |
1 |
2015 |
| Drug |
elbasvir |
1 |
2014 |
| Drug |
elbasvir 50 mg, zepatierâ® |
1 |
2018 |
| Biological |
electroporation-mediated plasmid dna vaccine therapy |
1 |
2016 |
| Drug |
ellagic acid |
1 |
2014 |
| Drug |
ellagic acid / annona muricata |
1 |
2014 |
| Drug |
eltrombopag |
1 |
2018 |
| Drug |
elvitegravir |
1 |
2016 |
| Drug |
elvitegravir, cobicistat, emtricitabine, |
1 |
2007 |
| Drug |
elvitegravir, cobicistat, emtricitabine,/tenofovir alafenamid fumarate |
1 |
2007 |
| Drug |
elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide/other medically-appropriate fda-approved antiretroviral therapy |
1 |
2016 |
| Device |
emdogainâ® |
1 |
2015 |
| Biological |
emm75 streptococcus pyogenes (gas m75, strain 611024) |
1 |
2017 |
| Drug |
emtricitabine-tenofovir |
1 |
2016 |
| Drug |
emtricitabine-tenofovir disoproxil fumarate (truvada [trv]) |
1 |
2010 |
| Drug |
emtricitabine-tenofovir disoproxil fumarate (truvada [trv]) tail |
1 |
2010 |
| Drug |
emtricitabine / tenofovir |
1 |
2020 |
| Drug |
emtricitabine 200mg |
1 |
2010 |
| Drug |
emtricitabine 200mg /tenofovir 300mg |
1 |
2010 |
| Drug |
emtricitabine fdc |
1 |
2013 |
| Drug |
emtricitabine/tenofovir df |
1 |
2006 |
| Drug |
emtricitabine/tenofovir disoproxil fumarate |
1 |
2003 |
| Drug |
emtricitabine/tenofovir disoproxil fumarate (ftc/tdf) |
1 |
2007 |
| Drug |
emtricitibine |
1 |
2008 |
| Device |
endoscopy |
1 |
2020 |
| Drug |
engerix-b |
1 |
2017 |
| Drug |
engerix b |
1 |
2015 |
| Other |
engineered room |
1 |
2015 |
| Behavioral |
enhanced antimicrobial stewardship commitment |
1 |
2017 |
| Behavioral |
enhanced antimicrobial stewardship commitment/feedback |
1 |
2017 |
| Behavioral |
enhanced education |
1 |
2019 |
| Behavioral |
enhanced partner therapy (ept) |
1 |
2008 |
| Drug |
entecavir with continued standard of care antiretroviral therapy |
1 |
2008 |
| Biological |
env 2-3 |
1 |
1999 |
| Drug |
epivir |
1 |
2004 |
| Drug |
eradication therapy (amoxicillin; esomeprazole; tinidazole; levofloxacin) |
1 |
2012 |
| Drug |
ertapenem 1000 mg |
1 |
2019 |
| Drug |
ertapenem intravenous |
1 |
2007 |
| placebo |
ertapenem placebo |
1 |
2010 |
| Drug |
ertapenem sodium (mk0826) |
1 |
2009 |
| Drug |
erythromycin |
1 |
2013 |
| Drug |
esomeprazole/amox/levo |
1 |
2015 |
| Drug |
esomeprazole/amox/levo/tetra |
1 |
2015 |
| Drug |
estradiol |
1 |
2020 |
| Drug |
estradiol ring |
1 |
2013 |
| Drug |
estring vaginal ring |
1 |
2019 |
| Drug |
estrogen therapy |
1 |
1999 |
| Drug |
ethambutol |
1 |
2017 |
| Drug |
ethanol-lock |
1 |
2017 |
| Drug |
etravirine |
1 |
2010 |
| Drug |
etravirine (intelence) |
1 |
2009 |
| Drug |
etv |
1 |
2019 |
| Device |
eus-guided fistulization axios |
1 |
2018 |
| Device |
eutrophill |
1 |
2010 |
| Behavioral |
evidence-based practice for improving quality (epiq) method |
1 |
2015 |
| Biological |
ex vivo-activated autologous lymph node lymphocytes |
1 |
2015 |
| Device |
ex vivo lung perfusion |
1 |
2019 |
| Behavioral |
exercise |
1 |
2010 |
| Biological |
expanded nk cells |
1 |
2020 |
| Behavioral |
expanded school-based handwashing promotion |
1 |
2010 |
| Behavioral |
experimental |
1 |
2010 |
| Biological |
experimental recombinant hepatitis b vaccine |
1 |
2010 |
| Biological |
experimental recombinant hepatitis b vaccine, hbig |
1 |
2010 |
| Biological |
experimental: split-virion, adjuvanted h1n1 vaccine of 15 î¼g |
1 |
2009 |
| Biological |
experimental: split-virion, adjuvanted h1n1 vaccine of 30 î¼g |
1 |
2009 |
| Biological |
experimental: split-virion, adjuvanted h1n1 vaccine of 7.5 î¼g |
1 |
2009 |
| Biological |
experimental: split-virion, non-adjuvanted h1n1 vaccine of 15 î¼g |
1 |
2009 |
| Behavioral |
explanation of peer navigator |
1 |
2017 |
| Behavioral |
explanation of peer navigator/session wrap (5 minutes) |
1 |
2017 |
| Drug |
extended |
1 |
2016 |
| Drug |
extended antibiotics |
1 |
2018 |
| Other |
extended pap |
1 |
2017 |
| Drug |
extra dosage - cefuroxime (750mg) i.v |
1 |
2015 |
| Drug |
ezetimibe 10mg oral tablet |
1 |
2019 |
| Drug |
f/r/taf |
1 |
2016 |
| Drug |
f/taf |
1 |
2016 |
| Drug |
f/taf placebo |
1 |
2016 |
| Drug |
f/tdf |
1 |
2016 |
| Drug |
f/tdf placebo |
1 |
2016 |
| Drug |
f901318 |
1 |
2018 |
| Behavioral |
facilitated referral |
1 |
2009 |
| Drug |
factive iv |
1 |
2013 |
| Drug |
factiveâ® tab |
1 |
2013 |
| Drug |
factiveâ® tab / factive iv |
1 |
2013 |
| Procedure |
faecal transplantation |
1 |
2019 |
| Drug |
failing arv regimen |
1 |
2019 |
| Drug |
famotidine |
1 |
2009 |
| Other |
fast track foley removal |
1 |
2017 |
| Other |
fasting |
1 |
2016 |
| Drug |
favipiravir |
1 |
2020 |
| Diagnostic Test |
fda-cleared naats |
1 |
2019 |
| Biological |
fecal microbiota transplantation (fmt) |
1 |
2016 |
| Biological |
fecal swab |
1 |
2020 |
| Diagnostic Test |
fecal volatile organic compounds under chemotherapy |
1 |
2018 |
| Other |
feces |
1 |
2016 |
| Other |
feedback reports |
1 |
2016 |
| Other |
feedback stewardship interventions to reduce unnecessary use of antimicrobials |
1 |
2019 |
| Drug |
fendrix |
1 |
2015 |
| Other |
fermented dairy product containing the probiotic lactobacillus casei dn-114 001 (actimelâ®) |
1 |
2009 |
| Dietary Supplement |
fermented quinoa |
1 |
2019 |
| Dietary Supplement |
fermented rice |
1 |
2013 |
| Dietary Supplement |
fermented whey concentrate |
1 |
2019 |
| Dietary Supplement |
ferripel-3, vitamins a&d drops |
1 |
2006 |
| Drug |
ferumoxytol |
1 |
2015 |
| Drug |
fiacitabine |
1 |
1999 |
| Drug |
fialuridine |
1 |
1999 |
| Other |
fibrinolytic group |
1 |
2016 |
| Drug |
filgrastim |
1 |
1999 |
| Device |
filmarray pcr multiplex-pct assay |
1 |
2020 |
| Device |
filmarrayâ„¢ gastrointestinal (gi) panel |
1 |
2014 |
| Drug |
finafloxacin |
1 |
2008 |
| Drug |
finafloxacin / amoxicillin |
1 |
2008 |
| Drug |
finafloxacin / esomeprazole |
1 |
2008 |
| Drug |
finafloxacin hydrochloride |
1 |
2007 |
| Diagnostic Test |
final breath volatile organic compounds |
1 |
2018 |
| Diagnostic Test |
final fecal volatile organic compounds |
1 |
2018 |
| Diagnostic Test |
final microbiome |
1 |
2018 |
| Device |
finger pulse oximeter |
1 |
2013 |
| placebo |
fish oil placebo |
1 |
2012 |
| Procedure |
fixation of the sternotomy with more than six wires |
1 |
2007 |
| Procedure |
flexible sigmoidoscopy |
1 |
2015 |
| Device |
flir one |
1 |
2014 |
| Dietary Supplement |
florababy |
1 |
2018 |
| Biological |
flulavalâ® tetra (15 âµg |
1 |
2016 |
| Biological |
flulavalâ® tetra (15 âµg/strain) |
1 |
2016 |
| Drug |
fluoroquinolones (besifloxacin ; ciprofloxacin ; gatifloxacin ; levofloxacin ; moxifloxacin ; ofloxacin ) |
1 |
2016 |
| Biological |
fluzoneâ® 2012-2013 formula ndc no 498281-012-50 |
1 |
2014 |
| Biological |
fluzoneâ® high-dose (60 âµg |
1 |
2016 |
| Biological |
fluzoneâ® high-dose (60 âµg/strain) |
1 |
2016 |
| Other |
fmt |
1 |
2017 |
| Biological |
fmt-c |
1 |
2019 |
| Biological |
fmt-c lactobacillus |
1 |
2019 |
| Biological |
focetriaâ® |
1 |
2009 |
| Behavioral |
focus on the future program |
1 |
2009 |
| Device |
foley catheter vs self-contained valved catheter |
1 |
2017 |
| Dietary Supplement |
follow on formula without probiotics |
1 |
2010 |
| Other |
force gauge |
1 |
2019 |
| Device |
forced air warming blanket |
1 |
2016 |
| Other |
formulation buffer |
1 |
2009 |
| Drug |
fortum (ceftazidime for injection usp) glaxo smith kline pharmaceuticals limited |
1 |
2006 |
| Drug |
fosamprenavir/ritonavir |
1 |
2007 |
| Drug |
fosfomycin disodium |
1 |
2017 |
| Drug |
fosfomycin sodium intravenous |
1 |
2014 |
| Drug |
fosmanogepix |
1 |
2020 |
| Other |
freeze dried strawberry powder |
1 |
2017 |
| Drug |
frio mouth rinse |
1 |
2008 |
| Drug |
ftc |
1 |
2017 |
| Drug |
ftc) |
1 |
2012 |
| Drug |
ftortiazinon (tablets 300 mg) 1 |
1 |
2018 |
| Drug |
ftortiazinon (tablets 300 mg) 1/2 dose /placebo/ maxipim |
1 |
2018 |
| Drug |
ftortiazinon (tablets 300 mg) full dose |
1 |
2018 |
| Drug |
ftortiazinon (tablets 300 mg) full dose / maxipim |
1 |
2018 |
| Drug |
fuganlin oral liquid |
1 |
2015 |
| Other |
full aseptic dressing |
1 |
2017 |
| Drug |
full boosted fosamprenavir |
1 |
2006 |
| Drug |
full spectrum microbiota |
1 |
2017 |
| Procedure |
fungal ulcer control |
1 |
2015 |
| Procedure |
fungal ulcer cross-linking |
1 |
2015 |
| Biological |
fvh1 - a dna-based influenza vaccine |
1 |
2012 |
| Drug |
g-csf |
1 |
2008 |
| Drug |
g-csf/dexamethasone |
1 |
2008 |
| Behavioral |
gamble school-based handwashing promotion program |
1 |
2010 |
| Biological |
gardasil |
1 |
2007 |
| Biological |
gardasil 9 |
1 |
2017 |
| Behavioral |
gargling |
1 |
2010 |
| Dietary Supplement |
gastimunhp plus |
1 |
2019 |
| Biological |
gbs vaccine |
1 |
2014 |
| Drug |
gene therapy method for cgd |
1 |
1999 |
| Biological |
genevax il-12-4532 |
1 |
2008 |
| Device |
gentamicin-impregnated implants |
1 |
2019 |
| Device |
gentamicin-impregnated implants/ sponges (sponge) |
1 |
2019 |
| Drug |
genvoya |
1 |
2018 |
| Drug |
genvoyaâ® |
1 |
2018 |
| Biological |
gla-af |
1 |
2017 |
| Biological |
gla-se |
1 |
2013 |
| Drug |
glecaprevir |
1 |
2019 |
| Drug |
glecaprevir 300 mg |
1 |
2019 |
| Drug |
glecaprevir 300 mg / pibrentasvir 120 mg oral tablet |
1 |
2019 |
| Drug |
glecaprevir/pibrentasvir (g/p) |
1 |
2019 |
| placebo |
glizigen placebo |
1 |
2018 |
| Dietary Supplement |
glizigenâ® |
1 |
2018 |
| Drug |
globulin, immune |
1 |
1999 |
| Other |
gloves |
1 |
2011 |
| Drug |
gls-1200 |
1 |
2020 |
| Biological |
gls-6150 |
1 |
2018 |
| Drug |
gls4 |
1 |
2019 |
| Drug |
glutamine |
1 |
2012 |
| Biological |
gne8 rgp120 |
1 |
1999 |
| Drug |
gno |
1 |
2018 |
| Behavioral |
goal-setting (5 minutes) |
1 |
2017 |
| Biological |
gp160 vaccine (microgenesys) |
1 |
1999 |
| Biological |
granulocyte transfusions |
1 |
2008 |
| Drug |
grazoprevir |
1 |
2014 |
| Drug |
grazoprevir / elbasvir |
1 |
2014 |
| Drug |
grazoprevir 100 mg |
1 |
2018 |
| Drug |
grazoprevir 100 mg/ elbasvir 50 mg, zepatierâ® |
1 |
2018 |
| Biological |
group b streptococcus trivalent vaccine |
1 |
2011 |
| Biological |
group b streptococcus vaccine |
1 |
2011 |
| Drug |
gs-5816 |
1 |
2014 |
| Drug |
gs-5885 tablet |
1 |
2011 |
| Drug |
gs-9256 |
1 |
2010 |
| Drug |
gs-9451 tablet |
1 |
2011 |
| Drug |
gs-9669 |
1 |
2013 |
| Drug |
gs-9857 |
1 |
2014 |
| Drug |
gsk1265744 10 mg |
1 |
2012 |
| Drug |
gsk1265744 10 mg oral solution |
1 |
2008 |
| Drug |
gsk1265744 5 mg tablet |
1 |
2008 |
| Drug |
gsk1265744 60 mg |
1 |
2012 |
| Drug |
gsk1322322 |
1 |
2010 |
| placebo |
gsk1322322 placebo |
1 |
2010 |
| placebo |
gsk1349572 placebo |
1 |
2010 |
| Drug |
gsk2140944 capsules |
1 |
2014 |
| Drug |
gsk2140944 lyophile |
1 |
2014 |
| Drug |
gsk2248761 formulation 1 |
1 |
2009 |
| Drug |
gsk2248761 formulation 2 |
1 |
2009 |
| Drug |
gsk2248761 formulation 2/4 |
1 |
2009 |
| Drug |
gsk2248761 formulation 3 |
1 |
2009 |
| Drug |
gsk2248761 reference formulation |
1 |
2009 |
| Drug |
gsk2248761 wbm capsule |
1 |
2010 |
| Drug |
gsk2248761 wbm tablet |
1 |
2010 |
| Drug |
gsk2248761 wbm tablet formulation 1 |
1 |
2010 |
| Drug |
gsk2248761 wbm tablet formulation 2 |
1 |
2010 |
| Drug |
gsk2248761 wbm tablet formulation 3 |
1 |
2010 |
| Drug |
gsk2838232 |
1 |
2017 |
| Drug |
gsk3640254 |
1 |
2017 |
| Drug |
gsk364735 |
1 |
2006 |
| Drug |
gsk364735 oral solution |
1 |
2006 |
| Drug |
gsk364735 oral solution/oral tablets |
1 |
2006 |
| Drug |
gsk580416 |
1 |
2007 |
| Drug |
gsk744 |
1 |
2014 |
| Drug |
gsk744 la |
1 |
2014 |
| Drug |
guaifenesin |
1 |
2010 |
| Biological |
gut infection challenge with m bovis |
1 |
2010 |
| Drug |
gw640385 |
1 |
2005 |
| Drug |
gynoclin v |
1 |
2013 |
| Drug |
gzr |
1 |
2017 |
| Drug |
gzr (50 mg |
1 |
2017 |
| Drug |
h. pylori treatment |
1 |
2005 |
| Dietary Supplement |
h2mf |
1 |
2017 |
| Biological |
h5 vlp pandemic influenza vaccine 10 âµg |
1 |
2009 |
| Biological |
h5 vlp pandemic influenza vaccine 20 âµg |
1 |
2009 |
| Biological |
h5 vlp pandemic influenza vaccine 5 âµg |
1 |
2009 |
| Biological |
h5n1 inactivated, split-virion influenza vaccine |
1 |
2007 |
| Biological |
h5n1 inactivated, split-virion pandemic influenza vaccine |
1 |
2007 |
| Procedure |
hair clipping |
1 |
2009 |
| Drug |
half-boosted fosamprenavir |
1 |
2006 |
| Drug |
halometasone triclosan |
1 |
2017 |
| Behavioral |
hand finger nail clipping |
1 |
2012 |
| Behavioral |
hand hygiene |
1 |
2007 |
| Other |
hand hygiene compliance observation with video camera surveillance system |
1 |
2019 |
| Other |
hand hygiene compliance observation with video camera surveillance system/performance feedback of the hh rates to hcws |
1 |
2019 |
| Other |
hand hygiene implementation strategy |
1 |
2016 |
| Behavioral |
hand hygiene improvement intervention |
1 |
2014 |
| Behavioral |
hand hygiene promotion |
1 |
2008 |
| Behavioral |
hand hygiene/educational material |
1 |
2007 |
| Behavioral |
hand washing with soap |
1 |
2012 |
| Behavioral |
hand washing with soap/hand finger nail clipping |
1 |
2012 |
| Behavioral |
handwashing |
1 |
2005 |
| Behavioral |
hbv vaccination self-efficacy intervention |
1 |
2009 |
| Drug |
hcmv-specific hyperimmune globulin (cytotectâ®) |
1 |
2009 |
| Biological |
hcv dna vaccine ino-8000 |
1 |
2016 |
| Diagnostic Test |
hcv rna self-test |
1 |
2019 |
| Other |
health-care associated infection (hcai) |
1 |
2017 |
| Behavioral |
health check-up for expectant moms |
1 |
2019 |
| Behavioral |
health education intervention |
1 |
2010 |
| Other |
health education learning package |
1 |
2019 |
| Behavioral |
health hygiene education |
1 |
2020 |
| Behavioral |
health promotion |
1 |
2013 |
| Behavioral |
health promotion intervention |
1 |
2009 |
| Behavioral |
healthy love workshop |
1 |
2006 |
| placebo |
heparin-saline placebo |
1 |
2011 |
| Device |
heparin impregnated central venous catheters |
1 |
2005 |
| Biological |
hepatitis a vaccine (inactivated) |
1 |
1999 |
| Biological |
hepatitis b vaccine (recombinant) |
1 |
2001 |
| Biological |
hepatitis b vaccine 3 dose schedule (0,1,2 month) |
1 |
2009 |
| Biological |
hiberix (haemophilus influenzae type b (hib) vaccine) |
1 |
2009 |
| Biological |
high-dose inactivated, split-virion influenza vaccine |
1 |
2006 |
| Biological |
high dose of h5 vlp vaccine |
1 |
2013 |
| Biological |
high dose of h5 vlp vaccine / alhydrogel |
1 |
2013 |
| Biological |
high dose of h5 vlp vaccine / gla-se |
1 |
2013 |
| Biological |
high dose of h7 vlp vaccine |
1 |
2013 |
| Biological |
high dose of h7 vlp vaccine / alhydrogel |
1 |
2013 |
| Drug |
high dose vitamin d |
1 |
2010 |
| Procedure |
high resolution anoscopy |
1 |
2014 |
| Procedure |
high resolution anoscopy biannually |
1 |
2014 |
| Dietary Supplement |
high strength cranberry |
1 |
2017 |
| Drug |
highly active antiretroviral therapy |
1 |
2007 |
| Behavioral |
hiv |
1 |
2006 |
| Biological |
hiv-1 |
1 |
1999 |
| Device |
hiv-1 antibody test kit |
1 |
2007 |
| Diagnostic Test |
hiv-1 rna testing |
1 |
2018 |
| Biological |
hiv-1 sf-2 |
1 |
1999 |
| Biological |
hiv-1mn |
1 |
1999 |
| Biological |
hiv gp120 |
1 |
2005 |
| Biological |
hiv gp120/neftat/as02a vaccine |
1 |
2005 |
| Behavioral |
hiv prevention intervention - project prissma - hiv i have my eye on you |
1 |
2009 |
| Behavioral |
hiv prevention scripted lesson plans |
1 |
2019 |
| Behavioral |
hiv testing |
1 |
2007 |
| Behavioral |
hiv testing/care services |
1 |
2007 |
| Behavioral |
hiv/aids 101 workshop |
1 |
2006 |
| Behavioral |
hombres: a lay health advisor approach to std prevention |
1 |
2005 |
| Other |
home-cov rule implementation |
1 |
2020 |
| Other |
homefirst |
1 |
2015 |
| Behavioral |
household cleaning/disinfection |
1 |
2007 |
| Biological |
hpv-16 |
1 |
2016 |
| Biological |
hpv-16/18 placebo |
1 |
2016 |
| Biological |
hpv-16/18 vaccine |
1 |
2016 |
| Biological |
hpv 16 |
1 |
2005 |
| Biological |
hpv 16/18 vlp as04 |
1 |
2005 |
| Procedure |
hpv detection in anal canal samples |
1 |
2016 |
| Drug |
hs-10234 |
1 |
2019 |
| Biological |
human fecal matter |
1 |
2013 |
| Biological |
human papillomavirus 9-valent vaccine, recombinant |
1 |
2020 |
| Drug |
human recombinant deoxyribonuclease (dnase) |
1 |
2018 |
| Biological |
hxtc |
1 |
2017 |
| Device |
hyalofemme |
1 |
2019 |
| Drug |
hybrid regimen |
1 |
2019 |
| Drug |
hybrid therapy |
1 |
2018 |
| Procedure |
hydrogen peroxide pretreatment group |
1 |
2014 |
| Drug |
hydroxychloroquine sulfate tablets |
1 |
2020 |
| Drug |
hydroxychloroquine sulfate tablets/lopinavir/ ritonavir oral tablets |
1 |
2020 |
| Other |
hygiene |
1 |
2010 |
| Behavioral |
hygienic recommendations |
1 |
2019 |
| Device |
ialuril |
1 |
2019 |
| Drug |
ibuprofen |
1 |
2011 |
| Procedure |
icd |
1 |
2008 |
| Procedure |
icd/pacemaker pocket revision |
1 |
2008 |
| Behavioral |
identifying |
1 |
2017 |
| Behavioral |
identifying/prioritizing needs (5 minutes) |
1 |
2017 |
| Drug |
iff flavor 316 282, paracetamol , phenylephrine, guaifenesin |
1 |
2012 |
| Biological |
ifn-î³ positive selected t-cells |
1 |
2013 |
| Diagnostic Test |
igg antibody test |
1 |
2020 |
| Diagnostic Test |
igm/igg rapid test |
1 |
2020 |
| Biological |
iiv |
1 |
2014 |
| Biological |
il-15 adjuvant |
1 |
2008 |
| Drug |
ilaprazole |
1 |
2015 |
| Drug |
ilaprazole / amoxicillin |
1 |
2015 |
| Drug |
im-01 |
1 |
2019 |
| Device |
imaging |
1 |
2005 |
| Drug |
imatinib |
1 |
2020 |
| Drug |
imi/rel |
1 |
2019 |
| Drug |
imi/rel fdc |
1 |
2017 |
| Drug |
imipenem / cilastatin |
1 |
2011 |
| Drug |
imipenem/cilastatin 500 mg |
1 |
2012 |
| Drug |
immediate-release guaifenesin |
1 |
2012 |
| Biological |
immunization with inactivated bacteria |
1 |
2005 |
| Biological |
immunological diagnosis tests |
1 |
2016 |
| Dietary Supplement |
impact advanced recovery |
1 |
2018 |
| Procedure |
implantation of a static, non-articulating cement spacer. |
1 |
2011 |
| Procedure |
implantation of an articulating spacer. |
1 |
2011 |
| Other |
implementation of prospective audit |
1 |
2019 |
| Other |
implementation of prospective audit/feedback stewardship interventions to reduce unnecessary use of antimicrobials/improve quality of prescriptions |
1 |
2019 |
| Behavioral |
implementation of the ao trauma ssi prevention bundle |
1 |
2017 |
| Other |
improve quality of prescriptions |
1 |
2019 |
| Device |
improved “injera” baking biomass stove |
1 |
2018 |
| Behavioral |
improved management of severe neonatal infections |
1 |
2005 |
| Behavioral |
improving gp antibiotics prescribing behaviour |
1 |
2013 |
| Biological |
inactivated split-virion influenza vaccine |
1 |
2006 |
| Biological |
inactivated, split-virion, influenza vaccine |
1 |
2008 |
| Device |
inactive household uv water treatment device |
1 |
2020 |
| Procedure |
incision |
1 |
2015 |
| Procedure |
incision/drainage |
1 |
2015 |
| Drug |
indinavir |
1 |
1999 |
| Drug |
indinavir (mk-0639) |
1 |
1999 |
| Other |
individual homeopathic treatment |
1 |
2011 |
| Other |
infection control measure |
1 |
2020 |
| Other |
infection prevention bundle |
1 |
2020 |
| Other |
influenza vaccine intervention |
1 |
2013 |
| Behavioral |
information-matched control |
1 |
2019 |
| Behavioral |
information pages |
1 |
2013 |
| Drug |
ingavirin (imidazolyl ethanamide pentandioic acid) |
1 |
2017 |
| Drug |
inhaled beclomethasone |
1 |
2015 |
| Drug |
inhaled molgramostim |
1 |
2018 |
| Drug |
inhaled primatene will be given as a breathing treatment |
1 |
2007 |
| Diagnostic Test |
initial breath volatile organic compounds |
1 |
2018 |
| Diagnostic Test |
initial fecal microbiome |
1 |
2018 |
| Diagnostic Test |
initial fecal volatile organic compounds |
1 |
2018 |
| Procedure |
injection of onabotulinumtoxina (btx-a) |
1 |
2018 |
| Device |
inpwt |
1 |
2013 |
| Dietary Supplement |
intake of food product with a patented fermented rye bran |
1 |
2016 |
| Dietary Supplement |
intake of food product with common refined wheat |
1 |
2016 |
| Behavioral |
integrated management of infectious disease (imid) |
1 |
2010 |
| Device |
integuseal |
1 |
2009 |
| Radiation |
intensity-modulated radiation therapy (imrt) |
1 |
2019 |
| Behavioral |
intensive education on personal hygiene |
1 |
2007 |
| Drug |
interferon alfa-n3 |
1 |
1999 |
| Drug |
interferon gamma |
1 |
1999 |
| Drug |
interferon gamma for aerosol |
1 |
2001 |
| Drug |
interferon gamma, gm-csf |
1 |
2005 |
| Drug |
interleukin-2 sa |
1 |
2003 |
| Other |
interrupted suturing |
1 |
2012 |
| Other |
interruption of antibiotic treatment due to pct measurement |
1 |
2016 |
| Procedure |
intervention arm 1: covering with approved abdominal 3mâ„¢ steri-drapeâ„¢ wound edge protector intervention arm 2: covering with standard woven swabs |
1 |
2010 |
| Other |
intervention cluster |
1 |
2017 |
| Other |
intervention: education, decision support tools |
1 |
2009 |
| Biological |
intestinal microbiota therapy |
1 |
2014 |
| Procedure |
intra-peritoneal antibiotic lavage |
1 |
2011 |
| Procedure |
intraoperative samples |
1 |
2016 |
| Drug |
intraperitoneal daptomycin |
1 |
2013 |
| Drug |
intravenous iclaprim |
1 |
2006 |
| Drug |
intravenous iclaprim/intravenous linezolid |
1 |
2006 |
| Biological |
intravenous injection of ebv specific ctls |
1 |
2003 |
| Drug |
intravenous levonadifloxacin |
1 |
2017 |
| Drug |
intravenous levonadifloxacin/linezolid infusion |
1 |
2017 |
| Drug |
intravenous linezolid |
1 |
2006 |
| Dietary Supplement |
inulin |
1 |
2010 |
| Drug |
inulin oral suspension |
1 |
2019 |
| Drug |
iodine |
1 |
2013 |
| Drug |
iodophor (10% povidone-iodine) |
1 |
2017 |
| Device |
iodophor antimicrobial incise drapes (drape) |
1 |
2019 |
| Procedure |
ionic silver-containing dressing |
1 |
2014 |
| Drug |
iramox |
1 |
2016 |
| Drug |
iron |
1 |
2006 |
| Dietary Supplement |
iron fumerate |
1 |
2015 |
| Device |
irrisept system |
1 |
2014 |
| Drug |
islatravir |
1 |
2019 |
| Other |
isocaloric powder |
1 |
2017 |
| Drug |
isolated 0.3% gatifloxacin |
1 |
2010 |
| Drug |
isolated 0.3% gatifloxacin/1.0% prednisolone acetate |
1 |
2010 |
| Device |
isolex 300i magnetic cell selector |
1 |
1999 |
| Drug |
isoniazid/rifapentine |
1 |
2012 |
| Drug |
isoniazid/rifapentine 12-weekly/pyridoxine (vitamin b6) |
1 |
2018 |
| Drug |
isoniazid/rifapentine daily (4 weeks)/pyridoxine (vitamin b6) |
1 |
2018 |
| Biological |
isopropyl alcohol |
1 |
2011 |
| Drug |
isotonic saline. |
1 |
2013 |
| placebo |
isotonic solution of sodium chloride (placebo) |
1 |
2009 |
| Drug |
isotretinoin |
1 |
1999 |
| Other |
its blankets. |
1 |
2016 |
| Drug |
iv aztreonam |
1 |
2007 |
| Drug |
iv dalbavancin |
1 |
2011 |
| Drug |
iv gamunex 10% |
1 |
2006 |
| Drug |
iv vancomycin/iv aztreonam |
1 |
2007 |
| Drug |
ivermectin treatment |
1 |
2005 |
| Drug |
ivig (privigen) |
1 |
2014 |
| Drug |
jing fang bai du san |
1 |
2009 |
| Drug |
jnj-32729463 |
1 |
2010 |
| placebo |
jnj-32729463 placebo |
1 |
2010 |
| Drug |
jnj-53718678 |
1 |
2015 |
| Drug |
juc solution |
1 |
2013 |
| Drug |
kaletra |
1 |
2004 |
| Drug |
ketoconazole |
1 |
1999 |
| Drug |
kg- 1 dose |
1 |
2014 |
| Drug |
kg - 2 doses |
1 |
2014 |
| Drug |
klacid |
1 |
2016 |
| Other |
km |
1 |
2019 |
| Other |
krp-ni |
1 |
2019 |
| Other |
krp-ni / km |
1 |
2019 |
| Dietary Supplement |
l-alanine |
1 |
2012 |
| Drug |
l-methionine, hibiscus sabdariffa |
1 |
2014 |
| Drug |
l-methionine, hibiscus sabdariffa/boswellia leaf extract |
1 |
2014 |
| Dietary Supplement |
l reuteri in children on antibiotics |
1 |
2011 |
| Other |
l reuteri pb-w1 strain |
1 |
2017 |
| Dietary Supplement |
l. acidophilus dds-1, b. lactis uabla-12 |
1 |
2012 |
| Other |
l. reuteri dsm20016t strain |
1 |
2017 |
| Other |
laboratory value procalcitonin |
1 |
2008 |
| Drug |
lactin-v |
1 |
2006 |
| Dietary Supplement |
lactobacillus fermentum |
1 |
2010 |
| Dietary Supplement |
lactobacillus gg |
1 |
2010 |
| Dietary Supplement |
lactobacillus helveticus r0052, bifidobacterium bifidum r0071, bifidobacterium infantis r0033 |
1 |
2008 |
| Dietary Supplement |
lactobacillus rhamnosus |
1 |
2012 |
| Other |
lactobacillus rhamnosus bmx 54 |
1 |
2017 |
| Dietary Supplement |
lactolevure |
1 |
2017 |
| Drug |
lactose |
1 |
2018 |
| Biological |
laiv |
1 |
2014 |
| Drug |
lamivudine-zidovudine (3tc-zdv) |
1 |
2010 |
| Drug |
lamivudine (abc |
1 |
2012 |
| Drug |
lamivudine (combivirâ®) |
1 |
2006 |
| Drug |
lamivudine (or emtricitabine) |
1 |
2009 |
| Drug |
lamivudine fdc |
1 |
2013 |
| Drug |
lansoprazole, clarithromycin, amoxycillin |
1 |
2007 |
| Drug |
lanzol |
1 |
2016 |
| Procedure |
laparoscopic surgery |
1 |
2014 |
| Other |
latent tuberculosis infection program evaluation |
1 |
2016 |
| Other |
latent tuberculosis infection program evaluation/diagnosis |
1 |
2016 |
| Drug |
ledipasvir |
1 |
2015 |
| Drug |
ledipasvir/sofosbuvir |
1 |
2015 |
| Drug |
letermovir iv |
1 |
2019 |
| Drug |
letermovir pill |
1 |
2019 |
| Drug |
letermovir tablet |
1 |
2019 |
| Procedure |
leukocyte depletion of whole blood |
1 |
2005 |
| Other |
leukocyte filtration |
1 |
2005 |
| Other |
leukocyte filtration/depletion |
1 |
2005 |
| Drug |
levocarnitine |
1 |
1999 |
| Drug |
levofloxacin (oral) |
1 |
2015 |
| placebo |
levofloxacin placebo |
1 |
2014 |
| Drug |
levofloxacin quadruple regimen |
1 |
2019 |
| Drug |
lff571 |
1 |
2010 |
| Biological |
lfmt |
1 |
2017 |
| Drug |
liberase enzyme |
1 |
2020 |
| Other |
linc-ii |
1 |
2017 |
| Drug |
linezolid 600 mg |
1 |
2018 |
| Drug |
linezolid infusion |
1 |
2017 |
| Drug |
linezolid tablet |
1 |
2017 |
| Drug |
liposomal amikacin for inhalation (arikayceâ„¢) using the pari investigational eflowâ® nebulizer. |
1 |
2011 |
| Drug |
liposomal amphotericin b |
1 |
1999 |
| Other |
liquid soap |
1 |
2017 |
| Drug |
lithium |
1 |
2011 |
| Other |
liver transplant |
1 |
2016 |
| Drug |
lobucavir |
1 |
1999 |
| Drug |
local application of collagen-gentamicin |
1 |
2007 |
| Other |
longer therapy duration |
1 |
2013 |
| Drug |
lopinavir-ritonavir (lpv-rtv) |
1 |
2010 |
| Drug |
lopinavir 400 mg |
1 |
2010 |
| Drug |
lopinavir 400 mg/ritonavir 100mg |
1 |
2010 |
| Drug |
lopinavir/ ritonavir oral tablet |
1 |
2020 |
| Drug |
lopinavir/ritonavir with two nucleoside analogs |
1 |
2009 |
| Biological |
low |
1 |
2020 |
| Biological |
low dose of h5 vlp vaccine |
1 |
2013 |
| Biological |
low dose of h5 vlp vaccine / alhydrogel |
1 |
2013 |
| Biological |
low dose of h5 vlp vaccine / gla-se |
1 |
2013 |
| Biological |
low dose of h7 vlp vaccine |
1 |
2013 |
| Biological |
low dose of h7 vlp vaccine / alhydrogel |
1 |
2013 |
| Other |
low fiber diet |
1 |
2019 |
| Drug |
low tacrolimus |
1 |
2012 |
| Biological |
low/upper respiratory tract sample |
1 |
2020 |
| Biological |
lsff |
1 |
2017 |
| Drug |
ltx-109 |
1 |
2010 |
| Procedure |
lumbar puncture |
1 |
2019 |
| Drug |
lumicitabine |
1 |
2017 |
| Procedure |
lung function measurement |
1 |
2015 |
| Procedure |
lymph node biospy |
1 |
1999 |
| Drug |
macrolide treatment |
1 |
2013 |
| Drug |
magnesium sulfate |
1 |
1999 |
| Procedure |
magnetic resonance imaging |
1 |
2015 |
| Drug |
magnex (sulbactam sodium |
1 |
2006 |
| Drug |
magnex (sulbactam sodium/cefoperazone sodium 1:1) pfizer ltd. |
1 |
2006 |
| Other |
mailing of antibiotic therapy guidelines to the sentinel physicians |
1 |
2011 |
| Drug |
maintenance of the current regimen |
1 |
2016 |
| Other |
malaria challenge infection, p. falciparum 3d7 |
1 |
2018 |
| Device |
malditof |
1 |
2014 |
| Behavioral |
male sexual health program |
1 |
2009 |
| Dietary Supplement |
maltodextrin |
1 |
2015 |
| Drug |
mannose |
1 |
2018 |
| Procedure |
manual bladder stimulation technique |
1 |
2019 |
| Drug |
maribavir |
1 |
1999 |
| Device |
mask, alcohol |
1 |
2007 |
| Device |
mask, alcohol/hand sanitizer |
1 |
2007 |
| Procedure |
mass closure |
1 |
2007 |
| Other |
matched donor human milk |
1 |
2019 |
| placebo |
matching placebo |
1 |
2019 |
| placebo |
matching placebo to relebactam |
1 |
2012 |
| Biological |
measles-mumps-rubella vaccine (live) |
1 |
2001 |
| Drug |
mebendazole 2 x 500mg |
1 |
2011 |
| Drug |
mebendazole 500mg |
1 |
2011 |
| Drug |
mebendazole polymorph a |
1 |
2011 |
| Drug |
mebendazole polymorph a/c 500 mg |
1 |
2011 |
| Drug |
mebendazole polymorph c |
1 |
2011 |
| Biological |
med dose of h5 vlp vaccine |
1 |
2013 |
| Biological |
med dose of h5 vlp vaccine / alhydrogel |
1 |
2013 |
| Biological |
med dose of h7 vlp vaccine |
1 |
2013 |
| Biological |
med dose of h7 vlp vaccine / alhydrogel |
1 |
2013 |
| Biological |
medi-524 |
1 |
2005 |
| Biological |
medi-534 |
1 |
2007 |
| Drug |
medi8897 |
1 |
2019 |
| Behavioral |
meditation |
1 |
2010 |
| Device |
medixairâ® |
1 |
2015 |
| Drug |
mefoxin 2g |
1 |
2019 |
| Biological |
men c conjugate |
1 |
2005 |
| Biological |
men c conjugate vaccine |
1 |
2005 |
| Biological |
menjugate |
1 |
2005 |
| Biological |
menjugate (meningococcal c conjugate vaccine) |
1 |
2008 |
| Device |
menstrual cup |
1 |
2017 |
| Drug |
meropenem intravenous |
1 |
2014 |
| Drug |
meropenem/imipenem |
1 |
2018 |
| Drug |
meropenem/saline placebo |
1 |
2010 |
| Drug |
mesalamine (5-aminosalicylic acid, apriso) |
1 |
2010 |
| Drug |
mesalazine 250mg |
1 |
2018 |
| Drug |
mesalazine 250mg tablet |
1 |
2018 |
| Drug |
mesalazine 250mg tablet/nitazoxanide 500mg oral tablet |
1 |
2018 |
| Drug |
met-2 |
1 |
2016 |
| Device |
metal retractor |
1 |
2016 |
| Drug |
metenkefalin |
1 |
2020 |
| Drug |
metenkefalin / tridecactide |
1 |
2020 |
| Drug |
metformin |
1 |
2016 |
| Drug |
methenamine hippurate |
1 |
2015 |
| Drug |
methotrexate |
1 |
1999 |
| Drug |
metrogyl (metronidazole injection ip) j.b.chemicals |
1 |
2006 |
| Drug |
metrogyl (metronidazole injection ip) j.b.chemicals/pharmaceuticals ltd. |
1 |
2006 |
| Drug |
metronidazole 1 g intravenous |
1 |
2015 |
| Drug |
metronidazole 250 mg oral |
1 |
2015 |
| Drug |
metronidazole 500 mg |
1 |
2016 |
| Drug |
metronidazole hydrochloride |
1 |
2017 |
| Drug |
metronizadole |
1 |
2005 |
| Drug |
mexiletine hydrochloride |
1 |
1999 |
| Biological |
mf-59 |
1 |
2005 |
| Biological |
mf59 |
1 |
1999 |
| Drug |
micafungin (mycamine) |
1 |
2008 |
| Diagnostic Test |
microbial culture |
1 |
2018 |
| Diagnostic Test |
microbiome under chemotherapy |
1 |
2018 |
| Procedure |
microdialysis |
1 |
2008 |
| Dietary Supplement |
micronutrient powder (mnp) |
1 |
2010 |
| Dietary Supplement |
micronutrients |
1 |
2008 |
| Dietary Supplement |
micronutrients/antioxidants |
1 |
2008 |
| Drug |
midazolam |
1 |
2011 |
| Dietary Supplement |
miglyol oil |
1 |
2010 |
| Drug |
mikacin (amikacin sulphate injection ip) aristo pharmaceuticals ltd. |
1 |
2006 |
| Other |
mild intraoperative hypercapnia (50 mmhg vs. 30 mmhg) |
1 |
2006 |
| Procedure |
mild soap skin cleanser |
1 |
2013 |
| Dietary Supplement |
mineral water |
1 |
2015 |
| Dietary Supplement |
minerals |
1 |
2008 |
| Biological |
mirasol-treated fresh whole blood |
1 |
2018 |
| Biological |
mk-3415 |
1 |
2010 |
| Drug |
mk-7655 |
1 |
2011 |
| Drug |
mk0518 (raltegravir) |
1 |
2009 |
| Drug |
mk0826, ertapenem sodium / duration of treatment - 24 weeks |
1 |
2005 |
| Drug |
mk0826, ertapenem sodium / duration of treatment: 14 days |
1 |
2006 |
| Drug |
mk0826, ertapenem sodium /duration of treatment: 14 days |
1 |
2007 |
| Drug |
mk0826; ertapenem sodium |
1 |
2005 |
| Drug |
ml) im given once on day 1. |
1 |
2015 |
| Drug |
mmh-407 |
1 |
2019 |
| Biological |
mn rgp120 |
1 |
1999 |
| Biological |
mn rgp120/hiv-1/gne8 rgp120/hiv-1 |
1 |
1999 |
| Drug |
modification for administration mode of cloxacillin antibiotic |
1 |
2017 |
| Drug |
molgramostim nebulizer solution |
1 |
2018 |
| Device |
mona lisa touch |
1 |
2020 |
| Drug |
monotherapy (lopinavir |
1 |
2009 |
| Drug |
monotherapy (lopinavir/ritonavir) |
1 |
2009 |
| Drug |
monotherapy (lopinavir/ritonavir) / abc/3tc |
1 |
2009 |
| Biological |
monovalent hbv vaccine |
1 |
2017 |
| Biological |
monovalent live attenuated pandemic influenza vaccine |
1 |
2009 |
| Biological |
montanide isa-51 adjuvant |
1 |
2019 |
| Drug |
monthly antibiotic |
1 |
2011 |
| placebo |
monthly placebo |
1 |
2011 |
| Procedure |
mouth-rinse with 0.12% clorhexidine |
1 |
2019 |
| Procedure |
mouth-rinse with isotonic solution with 1.5% sodium bicarbonate |
1 |
2019 |
| placebo |
moxifloxacin placebo |
1 |
2010 |
| Diagnostic Test |
mp diagnostics htlv blot 2.4 |
1 |
2017 |
| Other |
mr-proadm guided |
1 |
2018 |
| Diagnostic Test |
mri |
1 |
2019 |
| Biological |
mrkad5 hiv-1 gag |
1 |
2005 |
| Biological |
mrkad5 hiv-1 gag/pol/nef |
1 |
2005 |
| Biological |
mrkad5 hiv-1 gag/pol/nef placebo |
1 |
2005 |
| Biological |
mrna-transfected autologous dendritic cells |
1 |
2009 |
| Drug |
mrx-i |
1 |
2014 |
| Biological |
mtp-pe |
1 |
1999 |
| Biological |
mtp-pe/mf59 |
1 |
1999 |
| Genetic |
mucosal tissue sampling |
1 |
2017 |
| Dietary Supplement |
multi-strain probiotic |
1 |
2011 |
| Biological |
multi-virus specific t cells |
1 |
2010 |
| Behavioral |
multimodal hygiene intervention |
1 |
2018 |
| Diagnostic Test |
multiplex molecular diagnostic assay |
1 |
2017 |
| Biological |
multivirus specific t cells |
1 |
2014 |
| Dietary Supplement |
multivitamins |
1 |
2008 |
| Dietary Supplement |
multivitamins/minerals |
1 |
2008 |
| Drug |
mupirocin (bactroban) 2%; hexachlorophene (phisohex) 3% |
1 |
2008 |
| Drug |
mupirocin (drug) |
1 |
2006 |
| Drug |
mupirocin 2% nasal ointement |
1 |
2015 |
| Drug |
mupirocin ointment [treatment] |
1 |
2005 |
| Procedure |
mupirocin ointment application |
1 |
2014 |
| Drug |
mupirocin, chlorhexidine, |
1 |
2007 |
| Drug |
mupirocin, chlorhexidine,/household cleaning/disinfection |
1 |
2007 |
| Drug |
mupirocin/chlorhexidine |
1 |
2007 |
| Biological |
mva-b |
1 |
2008 |
| Biological |
mva-nsmut |
1 |
2014 |
| Biological |
mva.hivconsv |
1 |
2014 |
| Biological |
mva.hpv16 |
1 |
2018 |
| Biological |
mva.hpv16/18 |
1 |
2018 |
| Drug |
mycophenolic acid |
1 |
2014 |
| Drug |
mycophenolic acid dose reduction |
1 |
2012 |
| Drug |
n-acetyl cysteine (nac) |
1 |
2017 |
| Drug |
n-acetylcysteine |
1 |
2006 |
| Drug |
n-acetylcysteine/placebo |
1 |
2006 |
| Biological |
na-asp-2 |
1 |
2005 |
| Biological |
na-asp-2 skin test reagent |
1 |
2009 |
| Biological |
na-asp-2/alhydrogel hookworm vaccine |
1 |
2005 |
| Biological |
na-gst-1 |
1 |
2017 |
| Biological |
na-gst-1/alhydrogel |
1 |
2017 |
| Biological |
na-gst-1/alhydrogel / cpg 10104 |
1 |
2017 |
| Biological |
na-gst-1/alhydrogel / gla-af |
1 |
2017 |
| Drug |
nacl; saline |
1 |
2018 |
| Dietary Supplement |
nanotechnology structured water magnalife |
1 |
2020 |
| Dietary Supplement |
naringenin |
1 |
2010 |
| Drug |
nasal antiseptic |
1 |
2011 |
| Drug |
nasal mupirocin |
1 |
2010 |
| Drug |
nasal povidone iodine |
1 |
2014 |
| Diagnostic Test |
nasal swabs |
1 |
2017 |
| Other |
nasal swabs for mrsa culture |
1 |
2008 |
| Other |
nasal washing |
1 |
2007 |
| Diagnostic Test |
naso-pharyngeal swab |
1 |
2017 |
| Diagnostic Test |
naso-pharyngeal swab/sputum culture |
1 |
2017 |
| Other |
nasopharyngeal swab sampling |
1 |
2016 |
| Procedure |
nasopharyngeal washing for viral antigen detection by immunofluorescence initiated early in ed visit. |
1 |
2006 |
| Biological |
navitoclax |
1 |
2014 |
| Biological |
ndv-3 vaccine with alum im |
1 |
2011 |
| Biological |
ndv-3 vaccine without alum id |
1 |
2011 |
| Biological |
ndv-3 vaccine without alum im |
1 |
2011 |
| Drug |
nebulizer. |
1 |
2011 |
| Biological |
necator americanus hookworm larvae |
1 |
2013 |
| Biological |
necator americanus l3 larvae |
1 |
2017 |
| Other |
necator americanus larval inoculum |
1 |
2017 |
| Biological |
nef |
1 |
2005 |
| placebo |
nef placebo |
1 |
2005 |
| Biological |
neftat |
1 |
2005 |
| Device |
negative pressure pressure wound therapy |
1 |
2019 |
| Biological |
neisseria gonorrhoeae strain fa1090 a26 |
1 |
2019 |
| Biological |
neisseria gonorrhoeae strain fa7537 |
1 |
2019 |
| Biological |
neisvacc (meningococcal c conjugate vaccine) |
1 |
2008 |
| Drug |
nelfinavir |
1 |
2005 |
| Drug |
neomycin |
1 |
2017 |
| Diagnostic Test |
neumodx ct |
1 |
2019 |
| Diagnostic Test |
neumodx ct/ng assay |
1 |
2019 |
| Drug |
neutrolin |
1 |
2016 |
| Drug |
nevirapine (nvp): antepartum mothers |
1 |
2010 |
| Drug |
nevirapine (nvp): infant extended |
1 |
2010 |
| Drug |
nevirapine (nvp): infant short-course |
1 |
2010 |
| Drug |
nexium |
1 |
2016 |
| Drug |
nexium 20 mg |
1 |
2015 |
| Drug |
nexium 40 mg |
1 |
2015 |
| Diagnostic Test |
ng assay |
1 |
2019 |
| Drug |
nimorazole. |
1 |
2019 |
| Drug |
nitazoxanide |
1 |
2018 |
| Drug |
nitazoxanide (ntz) |
1 |
2009 |
| Drug |
nitazoxanide with pegylated interferon |
1 |
2010 |
| Drug |
nitazoxanide with pegylated interferon/ribavirin |
1 |
2010 |
| Drug |
nitric oxide 0.5 % |
1 |
2017 |
| Drug |
nitric oxide 0.5 % / nitrogen 99.5 % gas for inhalation |
1 |
2017 |
| Drug |
nitrofurantoin 100 mg |
1 |
2017 |
| Drug |
nitrofurantoin prophylaxis |
1 |
2018 |
| Drug |
nitrofurantoin prophylaxis/placebo |
1 |
2018 |
| Drug |
nitrogen 99.5 % gas for inhalation |
1 |
2017 |
| Drug |
nitroglycerin-citrate-ethanol (nice) |
1 |
2015 |
| Biological |
nk cells |
1 |
2020 |
| Drug |
no antibiotics |
1 |
2017 |
| Behavioral |
no feedback |
1 |
2012 |
| Other |
no intervention - standard of care (soc) only |
1 |
2014 |
| Drug |
no intervention; observational study |
1 |
2005 |
| Other |
no treatment |
1 |
2008 |
| Device |
no wound protector |
1 |
2010 |
| Biological |
non-adjuvanted high dose of quadrivalent vlp vaccine |
1 |
2014 |
| Biological |
non-adjuvanted low dose of quadrivalent vlp vaccine |
1 |
2014 |
| Biological |
non-adjuvanted medium dose of quadrivalent vlp vaccine |
1 |
2014 |
| Other |
non-chlorhexidine bathing |
1 |
2014 |
| Drug |
non-coated suture |
1 |
2018 |
| Device |
non-contact mce system |
1 |
2020 |
| Behavioral |
non-impositive program for optimizing the use of antimicrobials |
1 |
2019 |
| Drug |
non-quinolone antibiotic |
1 |
2008 |
| Procedure |
non absorbable suture group |
1 |
2012 |
| Other |
non fermented dairy product (control) |
1 |
2009 |
| Biological |
non pulsed dendritic cell untreated patients |
1 |
2006 |
| Biological |
non pulsed dendritic cell vaccine |
1 |
2006 |
| Other |
none (control) |
1 |
2019 |
| Drug |
nonoxynol-9 |
1 |
1999 |
| Procedure |
nopacking |
1 |
2008 |
| Other |
normal maternity pads |
1 |
2017 |
| Other |
normal saline irrigation |
1 |
2012 |
| Other |
normal wound dressing |
1 |
2017 |
| Other |
north american ginseng |
1 |
2009 |
| Other |
not |
1 |
2011 |
| Device |
not active |
1 |
2015 |
| Other |
notification cards |
1 |
2015 |
| Other |
nozinâ® nasal sanitizerâ® |
1 |
2013 |
| Device |
nucleic acid amplification test |
1 |
2005 |
| Diagnostic Test |
nucleic acid amplification test 1 for ng |
1 |
2016 |
| Diagnostic Test |
nucleic acid amplification test 1 for ng/ct |
1 |
2016 |
| Diagnostic Test |
nucleic acid amplification test 2 for ng |
1 |
2016 |
| Diagnostic Test |
nucleic acid amplification test 2 for ng/ct |
1 |
2016 |
| Diagnostic Test |
nucleic acid amplification test 3 for ng |
1 |
2016 |
| Diagnostic Test |
nucleic acid amplification test 3 for ng/ct |
1 |
2016 |
| Other |
nucleic acid amplification testing |
1 |
2011 |
| Behavioral |
nudge using behavioral economic interventions |
1 |
2018 |
| Behavioral |
nurse-led community health worker tbi (rn |
1 |
2018 |
| Behavioral |
nurse-led community health worker tbi (rn/chw tbi) program |
1 |
2018 |
| Other |
nurses informed |
1 |
2018 |
| Behavioral |
nutrition training |
1 |
2020 |
| Procedure |
nvhap prevention bundle |
1 |
2017 |
| Drug |
nxl103 |
1 |
2009 |
| Drug |
nxl104 |
1 |
2008 |
| Drug |
nxl104 (q12h) |
1 |
2011 |
| Drug |
nxl104 (q8h) |
1 |
2011 |
| Drug |
nystatin oral |
1 |
2017 |
| Other |
obemat2.0 therapy |
1 |
2018 |
| Other |
observation |
1 |
2010 |
| Drug |
obv |
1 |
2014 |
| Drug |
obv/ptv/r |
1 |
2014 |
| Drug |
ofloxacin |
1 |
1999 |
| Drug |
ofloxacine |
1 |
2015 |
| Drug |
ombitasvir, paritaprevir, ritonavir, dasabuvir |
1 |
2015 |
| Drug |
omega-3 fatty acids (fish oil) |
1 |
2012 |
| Drug |
omeprazole) |
1 |
2008 |
| Drug |
omeprazole/amoxicillin |
1 |
2009 |
| Drug |
omiganan 1% gel |
1 |
2005 |
| Dietary Supplement |
omniplus supreme |
1 |
2014 |
| Procedure |
on foley time |
1 |
2007 |
| Procedure |
one-stage exchange joint replacement surgery |
1 |
2016 |
| Drug |
one proton pump inhibitor, colloidal bismuth pectin |
1 |
2018 |
| Other |
online disease surveillance data access |
1 |
2010 |
| Other |
online tutorial |
1 |
2016 |
| Procedure |
open colorectal surgery |
1 |
2014 |
| Procedure |
open heart surgery |
1 |
2016 |
| Procedure |
open hernia repair |
1 |
2017 |
| Drug |
opioid based analgesia |
1 |
2008 |
| Device |
opsite post-op visible standard sterile dressing |
1 |
2018 |
| Drug |
optimized background regimen (obr) |
1 |
2019 |
| Other |
option 1: national comparison |
1 |
2019 |
| Other |
option 2: national comparison with benchmarking |
1 |
2019 |
| Diagnostic Test |
optional blood testing per standard of care (aso, anti-strep, ana, anti-ds-dna, hla-b27, rf, lyme |
1 |
2018 |
| Diagnostic Test |
optional blood testing per standard of care (aso, anti-strep, ana, anti-ds-dna, hla-b27, rf, lyme/other inflammatory/ rheumatologic markers ) |
1 |
2018 |
| Other |
optipac |
1 |
2016 |
| Drug |
oral anti-mrsa antibiotic |
1 |
2010 |
| Drug |
oral encochleated amphotericin b (camb) |
1 |
2016 |
| Drug |
oral lenacapavir |
1 |
2019 |
| Drug |
oral levonadifloxacin |
1 |
2017 |
| Drug |
oral levonadifloxacin/linezolid tablet |
1 |
2017 |
| Drug |
oral tablets |
1 |
2006 |
| Dietary Supplement |
ordinary bottled drinking water |
1 |
2020 |
| Drug |
oseltamivir |
1 |
2008 |
| Diagnostic Test |
other inflammatory |
1 |
2018 |
| Drug |
other medically-appropriate fda-approved antiretroviral therapy |
1 |
2016 |
| Behavioral |
overdose education |
1 |
2019 |
| Drug |
oxacillin |
1 |
2002 |
| Drug |
oxantel pamoate |
1 |
2017 |
| Drug |
oxygen |
1 |
2016 |
| Other |
oxygen by mask |
1 |
2009 |
| Drug |
p) |
1 |
2019 |
| Drug |
p1101 |
1 |
2020 |
| Drug |
p1101 / ribavirin |
1 |
2020 |
| Drug |
p128-0.1 mg |
1 |
2012 |
| Drug |
p128-0.3 mg |
1 |
2012 |
| Drug |
p128-1.0 mg |
1 |
2012 |
| Behavioral |
p3 vaccine promotion package. |
1 |
2012 |
| Procedure |
pacemaker pocket revision |
1 |
2008 |
| Behavioral |
package of targeted interventions to reduce error |
1 |
2006 |
| Drug |
paclitaxel |
1 |
2006 |
| Drug |
paracetamol |
1 |
2011 |
| Diagnostic Test |
parasitological diagnostics (coproscopy) |
1 |
2018 |
| Other |
parent leaflet |
1 |
2013 |
| Other |
parent survey |
1 |
2016 |
| Device |
parentaral antimicrobials |
1 |
2019 |
| Device |
parentaral antimicrobials/pure bone grafts |
1 |
2019 |
| Device |
pari eflow nebulizer system |
1 |
2018 |
| Procedure |
passive voiding trial |
1 |
2016 |
| Biological |
pathogen-specific ctls |
1 |
2017 |
| Behavioral |
patient-centered communication training |
1 |
2005 |
| Other |
patient-centered monitoring |
1 |
2017 |
| Procedure |
patient information leaflet (pil) |
1 |
2014 |
| Behavioral |
patient safety health information technology |
1 |
2016 |
| Biological |
patients treated by antibiotherapy |
1 |
2018 |
| Drug |
pclus 3-18 mn |
1 |
1999 |
| Drug |
pclus 6.1 mn |
1 |
1999 |
| Biological |
pcv10 |
1 |
2018 |
| Biological |
pcv13 |
1 |
2018 |
| Device |
pds ii |
1 |
2009 |
| Device |
pds plus |
1 |
2009 |
| Other |
pea fiber bar |
1 |
2019 |
| Other |
pears |
1 |
2017 |
| Behavioral |
peer-led intervention (peer) |
1 |
2017 |
| Drug |
peg |
1 |
2013 |
| Drug |
peg-interferon a-2b |
1 |
2005 |
| Drug |
peg-interferon a-2b / ribavirin |
1 |
2005 |
| Drug |
peg-intron |
1 |
2020 |
| Drug |
peg-intron / ribavirin |
1 |
2020 |
| Drug |
pegasys (tm) |
1 |
2014 |
| Biological |
pegfilgrastim |
1 |
2006 |
| Drug |
pegifn-2b |
1 |
2009 |
| Drug |
peginterferon |
1 |
2009 |
| Drug |
peginterferon alfa-2b |
1 |
2012 |
| Drug |
peginterferon alfa 2a |
1 |
2008 |
| Drug |
pegylated interferon-alpha 2a, 180 mcg |
1 |
2008 |
| Drug |
pegylated interferon-alpha 2a, 180 mcg/week sc |
1 |
2008 |
| Drug |
pegylated interferon-alpha 2a, 90 mcg |
1 |
2008 |
| Drug |
pegylated interferon-alpha 2a, 90 mcg/week sc |
1 |
2008 |
| Drug |
pegylated interferon a-2a (peginf) |
1 |
2013 |
| Drug |
pegylated interferon alfa-2a (peg) |
1 |
2009 |
| Drug |
pegylated interferon alfa-2a (pegifnî±-2a) |
1 |
2013 |
| Drug |
pegylated interferon alfa-2a / ribavirin |
1 |
2009 |
| Drug |
pegylated interferon alpha 2-a (pegifn) |
1 |
2013 |
| Drug |
pembrolizumab |
1 |
2017 |
| Drug |
pentasa vs align |
1 |
2018 |
| Drug |
pentoxifylline |
1 |
1999 |
| Biological |
peptides on autologous dendritic cells |
1 |
2009 |
| Procedure |
percutaneous isolated limb perfusion (pilp) delivery |
1 |
2014 |
| Other |
performance feedback of the hh rates to hcws |
1 |
2019 |
| Drug |
perineally immediately prior to surgery. |
1 |
2019 |
| Procedure |
perineural catheterization implementation |
1 |
2016 |
| Procedure |
perioperative supplemental oxygen |
1 |
2005 |
| Other |
perioperative warming with forced air warming device |
1 |
2016 |
| Procedure |
peripheral lymphocyte infusion |
1 |
1999 |
| Procedure |
periprocedural antibiotics |
1 |
2018 |
| Procedure |
perirectal swab sampling |
1 |
2016 |
| Drug |
personal medication history guided therapy |
1 |
2018 |
| Other |
pet scan |
1 |
2009 |
| Biological |
pfspz-dvi challenge |
1 |
2020 |
| Drug |
pharmaceuticals ltd. |
1 |
2006 |
| Behavioral |
pharmacist-led intervention (pharm) |
1 |
2017 |
| Other |
pharmacological study |
1 |
2014 |
| Drug |
phenazopyridine hydrochloride tables, usp 200 mg |
1 |
2012 |
| Drug |
phenoxymethylpenicillin |
1 |
2019 |
| Other |
phone call |
1 |
2020 |
| Procedure |
photodynamic treatment |
1 |
2019 |
| Other |
physical assessment |
1 |
2016 |
| Drug |
physiological saline |
1 |
2018 |
| Drug |
pi |
1 |
2016 |
| Drug |
pibrentasvir (g |
1 |
2019 |
| Drug |
pibrentasvir 120 mg oral tablet |
1 |
2019 |
| Drug |
piperacillin continuous infusion |
1 |
2010 |
| Drug |
piperacillin extended infusion |
1 |
2010 |
| Drug |
piperacillin sodium |
1 |
2012 |
| Drug |
piperacillin sodium/sulbactam sodium |
1 |
2012 |
| Drug |
piperacillin, tazobactam 4-0.5g solution for injection |
1 |
2019 |
| Drug |
piperacillin/tazobactam-matching placebo |
1 |
2011 |
| Drug |
piperacillin/tazobactam sodium |
1 |
2011 |
| Drug |
piperacillin/tazobactam/amoxicillin/clavulanic acid |
1 |
2006 |
| Drug |
piperaquine (high dose) |
1 |
2018 |
| Drug |
piperaquine (low dose) |
1 |
2018 |
| placebo |
placebo (liquid dosage form) |
1 |
2017 |
| placebo |
placebo (saline for injection) |
1 |
2019 |
| placebo |
placebo (saline solution) |
1 |
2009 |
| placebo |
placebo beverage |
1 |
2013 |
| placebo |
placebo capsule |
1 |
2018 |
| placebo |
placebo cloth |
1 |
2015 |
| placebo |
placebo comparator recombinant hepatitis b vaccine |
1 |
2010 |
| placebo |
placebo comparator: placebo |
1 |
2013 |
| placebo |
placebo comparator: placebo control |
1 |
2009 |
| placebo |
placebo cranberry juice |
1 |
2004 |
| placebo |
placebo cream |
1 |
2012 |
| placebo |
placebo faecal transplantation |
1 |
2019 |
| placebo |
placebo for abt-493 |
1 |
2015 |
| Drug |
placebo for abt-493/abt-530 |
1 |
2015 |
| placebo |
placebo for arabinoxylan rice bran |
1 |
2016 |
| placebo |
placebo for metronidazole |
1 |
2017 |
| placebo |
placebo gel |
1 |
2003 |
| placebo |
placebo group |
1 |
2008 |
| placebo |
placebo linezolid |
1 |
2014 |
| placebo |
placebo matched to suptavumab |
1 |
2014 |
| placebo |
placebo matching ribavirin tablet |
1 |
2011 |
| placebo |
placebo matching tegobuvir capsule |
1 |
2011 |
| placebo |
placebo matching with bms-955176 |
1 |
2013 |
| placebo |
placebo of ofloxacine |
1 |
2015 |
| placebo |
placebo of phenazopyridine hydrochloride tables, usp 200 mg |
1 |
2012 |
| placebo |
placebo ointment |
1 |
2008 |
| placebo |
placebo oral suspension |
1 |
2019 |
| placebo |
placebo powder capsules |
1 |
2011 |
| placebo |
placebo tedizolid (bay119-2631) |
1 |
2014 |
| placebo |
placebo to arctuvan |
1 |
2017 |
| placebo |
placebo to boceprevir |
1 |
2009 |
| placebo |
placebo to cms |
1 |
2015 |
| placebo |
placebo to fosfomycin |
1 |
2017 |
| placebo |
placebo to match gs-9857 |
1 |
2014 |
| placebo |
placebo to match ldv |
1 |
2013 |
| Drug |
placebo to match ldv/sof |
1 |
2013 |
| placebo |
placebo to match rbv |
1 |
2013 |
| placebo |
placebo to metronidazole |
1 |
2010 |
| placebo |
placebo to relebactam |
1 |
2012 |
| placebo |
placebo with alum im |
1 |
2011 |
| placebo |
placebo with no booster in stage 2 |
1 |
2009 |
| Other |
placebo/maxipim |
1 |
2018 |
| Drug |
placebo/standard of care |
1 |
2010 |
| Other |
plain soap |
1 |
2009 |
| Other |
plain soap/water (psw) |
1 |
2009 |
| Other |
plant based diet |
1 |
2017 |
| Biological |
plasma |
1 |
2020 |
| Diagnostic Test |
plasmatic ngal |
1 |
2019 |
| Diagnostic Test |
plasmatic ngal/mri |
1 |
2019 |
| Procedure |
pleural biopsy sampling |
1 |
2015 |
| Drug |
pmx-30063-investigational drug |
1 |
2010 |
| Biological |
pneumococcal conjugate 13 valent vaccine |
1 |
2013 |
| Biological |
pneumococcal vaccine formulation 4 |
1 |
2011 |
| Biological |
pneumococcal vaccine formulation 5 |
1 |
2011 |
| Biological |
pneumococcal vaccine high dose (formulation 1) |
1 |
2011 |
| Biological |
pneumococcal vaccine low dose (formulation 2) |
1 |
2011 |
| Biological |
pneumococcal vaccine middle dose (formulation 3) |
1 |
2011 |
| Biological |
pneumococcal vaccine middle dose (formulation 4) |
1 |
2011 |
| Biological |
pneumovax |
1 |
2006 |
| Diagnostic Test |
point of care early infant diagnosis |
1 |
2019 |
| Biological |
pol |
1 |
2005 |
| Drug |
polihexanide; serasept |
1 |
2018 |
| Drug |
poly-iclc |
1 |
2010 |
| Drug |
polyethylene glycol |
1 |
2017 |
| placebo |
polyethylene glycol ointment [placebo] |
1 |
2005 |
| Drug |
polyethylene glycol solution for daily bowel lavage. |
1 |
2012 |
| Drug |
posaconazole 200 mg |
1 |
2013 |
| Drug |
posaconazole 300 mg |
1 |
2013 |
| Behavioral |
positive deviance |
1 |
2014 |
| Other |
postoperative early shower |
1 |
2020 |
| Drug |
povidine-iodine |
1 |
2018 |
| Drug |
povidon iodine |
1 |
2016 |
| Procedure |
povidone |
1 |
2012 |
| Drug |
povidone-iodine 10% |
1 |
2005 |
| Other |
povidone iodine |
1 |
2014 |
| Drug |
povidone iodine 1% solution |
1 |
2018 |
| Drug |
povidone iodine 10% vand cesarean section wound infections |
1 |
2012 |
| Drug |
povidone iodine 7.5% vand cesarean section wound infections |
1 |
2012 |
| Drug |
povidone/iodine |
1 |
2006 |
| Drug |
pp4001 |
1 |
2011 |
| Drug |
praziquantel |
1 |
2007 |
| Dietary Supplement |
prebiotic inulin-type fructan |
1 |
2017 |
| Dietary Supplement |
prebiotic inulin-type fructans |
1 |
2018 |
| Drug |
premarin vaginal cream |
1 |
2012 |
| Other |
preparing skin’s areas to be tested |
1 |
2011 |
| Other |
preparing skin’s areas to be tested with two antiseptics |
1 |
2013 |
| Other |
preparing skin’s areas to be tested with two antiseptics/two controls |
1 |
2013 |
| placebo |
presatovir placebo |
1 |
2014 |
| Other |
preterm infant formula |
1 |
2017 |
| Device |
prevana dressing |
1 |
2015 |
| Device |
prevena |
1 |
2018 |
| Device |
prevena dressing |
1 |
2015 |
| Device |
prevena negative pressure wound system |
1 |
2012 |
| Device |
prevenaâ„¢ ims |
1 |
2015 |
| Device |
prevenaâ„¢ incision management system (pims) |
1 |
2011 |
| Biological |
prevenar13 |
1 |
2012 |
| Procedure |
prevention |
1 |
2020 |
| Drug |
preventive treatment with isoniazid |
1 |
2010 |
| Drug |
preventive treatment with isoniazid. |
1 |
2010 |
| Biological |
prevnar |
1 |
2006 |
| Biological |
prevnar-13 |
1 |
2018 |
| Biological |
prevnar 13â® |
1 |
2014 |
| Other |
prewarming |
1 |
2016 |
| Other |
prewarming/perioperative warming with forced air warming device/its blankets. |
1 |
2016 |
| Drug |
primaquine |
1 |
2014 |
| Procedure |
primary closure |
1 |
2015 |
| Procedure |
primary wound closure |
1 |
2012 |
| Behavioral |
prioritizing needs (5 minutes) |
1 |
2017 |
| Drug |
pritelivir |
1 |
2017 |
| Drug |
pro 140 |
1 |
2008 |
| Drug |
pro 140 (humanized monoclonal antibody to ccr5) |
1 |
2008 |
| Drug |
pro 2000/5 |
1 |
2005 |
| Drug |
pro 2000/5 gel |
1 |
2003 |
| Drug |
probenecid |
1 |
2017 |
| Dietary Supplement |
probi defendum |
1 |
2015 |
| Dietary Supplement |
probiotic (2 * 10^9 cfu |
1 |
2014 |
| Dietary Supplement |
probiotic (2 * 10^9 cfu/day) |
1 |
2014 |
| Dietary Supplement |
probiotic capsule gr-1 |
1 |
2018 |
| Dietary Supplement |
probiotic capsule gr-1/rc-14 |
1 |
2018 |
| Dietary Supplement |
probiotics lactobacillus acidophilus boucardii |
1 |
2014 |
| Dietary Supplement |
probiotics product |
1 |
2020 |
| Biological |
procalcitonin dosages |
1 |
2012 |
| Procedure |
procalcitonin guided antibiotic therapy |
1 |
2004 |
| Behavioral |
procter |
1 |
2010 |
| Behavioral |
procter/gamble school-based handwashing promotion program |
1 |
2010 |
| Behavioral |
progressive resistance exercise training |
1 |
2007 |
| Behavioral |
prolonged mechanical ventilation |
1 |
2006 |
| Drug |
propan-2-ol |
1 |
2013 |
| Drug |
prophylaxis of opportunistic infections |
1 |
2007 |
| Drug |
prophylaxis of opportunistic infections/support treatment |
1 |
2007 |
| Drug |
propofol |
1 |
2020 |
| Device |
prospective tdm arm of colistin |
1 |
2013 |
| Device |
protapernext x3 gutta-percha |
1 |
2018 |
| Drug |
provodine |
1 |
2015 |
| Drug |
prulifloxacin |
1 |
2014 |
| placebo |
prulifloxacin placebo |
1 |
2014 |
| Behavioral |
psycho-educational content (5 minutes) |
1 |
2017 |
| Drug |
ptv |
1 |
2014 |
| Biological |
pulsed dendritic cell vaccine |
1 |
2006 |
| Device |
pulsed uv device |
1 |
2017 |
| Device |
pure bone grafts |
1 |
2019 |
| Biological |
pyo phage |
1 |
2017 |
| Drug |
pyrantel-oxantel |
1 |
2011 |
| Drug |
pyrantel-oxantel / mebendazole |
1 |
2011 |
| Drug |
pyrantel pamoate |
1 |
2017 |
| Drug |
pyridoxine (vitamin b6) |
1 |
2018 |
| Drug |
pyrimethamine |
1 |
1999 |
| Drug |
pz-601 |
1 |
2008 |
| Biological |
quadrivalent comparator vaccine |
1 |
2018 |
| Biological |
quadrivalent hpv vaccine |
1 |
2014 |
| Biological |
quadrivalent vlp influenza vaccine |
1 |
2017 |
| Combination Product |
quadruple therapy |
1 |
2019 |
| Other |
quality of life questionary |
1 |
2016 |
| Other |
quaternary ammonium |
1 |
2012 |
| Other |
quaternary ammonium/uv-c light |
1 |
2012 |
| Drug |
r-chop |
1 |
2007 |
| Behavioral |
r - autodialers |
1 |
2017 |
| Behavioral |
r - mailed postcard |
1 |
2017 |
| Behavioral |
r - texting |
1 |
2017 |
| Drug |
r monotherapy (kaletra) |
1 |
2009 |
| Drug |
r) |
1 |
2007 |
| Behavioral |
r/r - autodialers |
1 |
2017 |
| Behavioral |
r/r - mailed postcard |
1 |
2017 |
| Behavioral |
r/r - texting |
1 |
2017 |
| Drug |
rabeprazole |
1 |
2015 |
| Drug |
rabeprazole-based triple therapy |
1 |
2015 |
| Drug |
rabeprazole sodium |
1 |
2005 |
| Drug |
rabeprazole, metronidazole, clarithromycin, amoxicillin |
1 |
2010 |
| Drug |
rabeprazole/3 antibiotics |
1 |
2015 |
| Drug |
rabeprazole/amox/tetr/levo |
1 |
2015 |
| Drug |
rabeprazole/bismuth/2 antibiotics |
1 |
2015 |
| Drug |
radezolid |
1 |
2008 |
| Drug |
raltegravir (isentress) |
1 |
2010 |
| placebo |
raltegravir placebo |
1 |
2010 |
| Drug |
raltegravir qd |
1 |
2009 |
| Drug |
raltegravir. |
1 |
2008 |
| Drug |
raltegravir; maraviroc; darunavir; ritonavir; tenofovir |
1 |
2009 |
| Drug |
raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine |
1 |
2009 |
| Diagnostic Test |
rapid diagnostics alone |
1 |
2017 |
| Other |
rapid molecular mrsa test |
1 |
2008 |
| Device |
rapid respiratory pathogen nucleic acid amplification test |
1 |
2016 |
| Drug |
ravuconazole |
1 |
2003 |
| Biological |
rbx7455 |
1 |
2016 |
| Dietary Supplement |
rc-14 |
1 |
2018 |
| Behavioral |
re-entry health linkage |
1 |
2019 |
| Behavioral |
readiness assessment (10 minutes) |
1 |
2017 |
| Dietary Supplement |
ready to use therapeutic food (rutf) |
1 |
2010 |
| Other |
real-time antimicrobial stewardship decision support |
1 |
2017 |
| Biological |
recombinant human papillomavirus nonavalent vaccine |
1 |
2017 |
| Biological |
recombinant interferon gamma |
1 |
2003 |
| Drug |
reconvan, dipeptiven, omegaven |
1 |
2008 |
| Procedure |
rectal swab |
1 |
2019 |
| Other |
reduced number of pills |
1 |
2009 |
| Drug |
rel |
1 |
2019 |
| Drug |
rel fdc |
1 |
2017 |
| Other |
release of test results |
1 |
2013 |
| Behavioral |
reminders |
1 |
2018 |
| Procedure |
removal of infected implant |
1 |
2017 |
| Drug |
rep 2139-ca |
1 |
2014 |
| Drug |
rep 2139-ca / pegasys (tm) |
1 |
2014 |
| Other |
rephresh pro-b |
1 |
2019 |
| Procedure |
respiratory bundle |
1 |
2020 |
| Procedure |
respiratory bundle/prevention |
1 |
2020 |
| Biological |
respiratory tract sample |
1 |
2020 |
| Drug |
retapamulin (altabax) |
1 |
2010 |
| Drug |
retapamulin ointment, 1% |
1 |
2007 |
| Other |
retrospective examination by experts whether care given fo child admitted at the icu for suspicion of bacterial infection (not nosocomial) was optimal |
1 |
2011 |
| Other |
retrospective examination by experts whether care given fo child admitted at the icu for suspicion of bacterial infection (not nosocomial) was optimal/not |
1 |
2011 |
| Drug |
reverse hybrid regimen |
1 |
2019 |
| Drug |
reverse hybrid therapy |
1 |
2015 |
| Drug |
rezafungin for injection |
1 |
2020 |
| Biological |
rgp120 |
1 |
1999 |
| Biological |
rgp120/hiv-1 sf-2 |
1 |
1999 |
| Biological |
rgp120/hiv-1mn |
1 |
1999 |
| Diagnostic Test |
rheumatologic markers ) |
1 |
2018 |
| Biological |
ri-001 |
1 |
2008 |
| Drug |
ribavirin tablet |
1 |
2011 |
| Other |
riboflavin |
1 |
2012 |
| Drug |
rifabutin in combination with efavirenz |
1 |
2008 |
| Drug |
rifabutin in combination with lopinavir |
1 |
2008 |
| Drug |
rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1 |
1 |
2008 |
| Drug |
rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2 |
1 |
2008 |
| Drug |
rifabutin in combination with lopinavir/ritonavir |
1 |
2008 |
| Drug |
rifabutin in combination with nevirapine |
1 |
2008 |
| Drug |
rifalazil 25 milligram |
1 |
2012 |
| Biological |
rifampicin dosages |
1 |
2016 |
| Drug |
rifapentine 12-weekly |
1 |
2018 |
| Drug |
rifapentine daily (4 weeks) |
1 |
2018 |
| Drug |
rilpivirine |
1 |
2007 |
| Drug |
rilpivirine - injectable suspension (rpv la) |
1 |
2016 |
| Drug |
rilpivirine (rpv) tablet |
1 |
2016 |
| Drug |
ritonavir ( |
1 |
2007 |
| Drug |
ritonavir 100mg |
1 |
2010 |
| Drug |
ritonavir oral tablet |
1 |
2020 |
| Drug |
ritonavir oral tablets |
1 |
2020 |
| Drug |
ritonavir with two nucleoside analogs |
1 |
2009 |
| Drug |
ritonavir, abt-267 |
1 |
2012 |
| Drug |
rivaroxaban, 10 mg |
1 |
2014 |
| Drug |
rivaroxaban, 7.5 mg |
1 |
2014 |
| Drug |
rivastigmine |
1 |
2011 |
| Drug |
ro 24-7429 |
1 |
1999 |
| Drug |
ro7079901 |
1 |
2017 |
| Drug |
ro7239958 |
1 |
2018 |
| Biological |
rotateq |
1 |
2009 |
| Other |
routine clinical microbiology |
1 |
2014 |
| Drug |
rpv fdc |
1 |
2016 |
| Biological |
rsv a memphis 37 |
1 |
2011 |
| Biological |
rsv a2 |
1 |
2017 |
| Drug |
rsv polyclonal immunoglobulin |
1 |
1999 |
| Drug |
rtv |
1 |
2019 |
| Biological |
ruti |
1 |
2010 |
| placebo |
ruti matching placebo |
1 |
2010 |
| Drug |
ruzasvir |
1 |
2014 |
| Drug |
rv521 oral tablet |
1 |
2020 |
| Drug |
s-649266 |
1 |
2016 |
| Drug |
s. aureus |
1 |
2014 |
| placebo |
sa3ag followed by placebo |
1 |
2009 |
| Biological |
sa3ag vaccine |
1 |
2009 |
| Biological |
sa3ag with no booster in stage 2 |
1 |
2009 |
| Dietary Supplement |
sachet with cranberry |
1 |
2017 |
| Dietary Supplement |
sachet with cranberry / placebo |
1 |
2017 |
| Drug |
saline 0.9% |
1 |
2014 |
| Procedure |
saline lavage |
1 |
2010 |
| Procedure |
saliva swab |
1 |
2010 |
| Biological |
salmonella typhi challenge |
1 |
2019 |
| Drug |
salvage treatment for failed eradication |
1 |
2018 |
| Genetic |
sb-728-t |
1 |
2010 |
| Drug |
sb9200 |
1 |
2013 |
| Behavioral |
school-based sexuality |
1 |
2019 |
| Behavioral |
school-based sexuality/hiv prevention scripted lesson plans |
1 |
2019 |
| Other |
screen-and-treat |
1 |
2013 |
| Other |
screen of crkp |
1 |
2020 |
| Other |
screen of crkp/infection control measure |
1 |
2020 |
| Behavioral |
script |
1 |
2015 |
| Drug |
scrt |
1 |
2009 |
| Drug |
sdz msl-109 |
1 |
2000 |
| Dietary Supplement |
selenium |
1 |
2005 |
| Procedure |
self-collected vaginal swab for chlamydia testing |
1 |
2005 |
| Behavioral |
self administered therapy (sat) |
1 |
2012 |
| Drug |
selinexor |
1 |
2020 |
| Drug |
semi-synthetic penicillins (ssps) |
1 |
2010 |
| Procedure |
sequenced bilateral tka |
1 |
2020 |
| Diagnostic Test |
serum c-reactive protein (crp) |
1 |
2018 |
| Diagnostic Test |
serum cell count |
1 |
2018 |
| Diagnostic Test |
serum cell count / differential (cbc) |
1 |
2018 |
| Diagnostic Test |
serum d-dimer |
1 |
2018 |
| Diagnostic Test |
serum erythrocyte sedimentation rate (esr) |
1 |
2018 |
| Diagnostic Test |
serum procalcitonin |
1 |
2018 |
| Behavioral |
session wrap (5 minutes) |
1 |
2017 |
| Drug |
sevirumab |
1 |
1999 |
| Drug |
sevoflurane |
1 |
2020 |
| Drug |
sh229 |
1 |
2018 |
| Device |
sham device |
1 |
2017 |
| Device |
sharklet catheter insertion |
1 |
2016 |
| Other |
short pap |
1 |
2017 |
| Drug |
short treatment (ciprofloxacin) |
1 |
2008 |
| Other |
shortened course of antibiotic therapy |
1 |
2008 |
| Other |
shorter therapy duration |
1 |
2013 |
| Drug |
sildenafil |
1 |
2013 |
| Device |
silicone foley catheter insertion |
1 |
2016 |
| Device |
silicone urinary catheter |
1 |
2010 |
| Device |
silver doped hydroxyapatite coated implants |
1 |
2017 |
| Drug |
silver nanoparticles |
1 |
2018 |
| Device |
silver spc |
1 |
2011 |
| Other |
silverlon |
1 |
2010 |
| Behavioral |
simple reminder |
1 |
2015 |
| Procedure |
simultaneous bilateral total knee arthroplasty |
1 |
2020 |
| Drug |
single arm (ganciclovir |
1 |
2008 |
| Drug |
single arm (ganciclovir/valganciclovir) |
1 |
2008 |
| Drug |
sitafloxacin |
1 |
2016 |
| Drug |
site-specific empiric regimens included: meropenem |
1 |
2007 |
| Behavioral |
skin intervention |
1 |
2013 |
| Drug |
skin prep benzoyl peroxide |
1 |
2015 |
| Drug |
skin prep chlorhexidine |
1 |
2015 |
| Procedure |
small stitches |
1 |
2007 |
| Diagnostic Test |
smart catheter biosensor |
1 |
2020 |
| Behavioral |
smart form |
1 |
2005 |
| Behavioral |
sms reminders |
1 |
2012 |
| Drug |
smx) |
1 |
2020 |
| Other |
smz prophylaxis |
1 |
2011 |
| Behavioral |
social media |
1 |
2013 |
| Behavioral |
social media/information pages |
1 |
2013 |
| Other |
sodium chloride |
1 |
2014 |
| Drug |
sodium mycophenolate |
1 |
2012 |
| Drug |
sof/gs-5816 |
1 |
2014 |
| Drug |
sofosbuvir, ribavirin, |
1 |
2014 |
| Drug |
sofosbuvir, ribavirin,/stribild |
1 |
2014 |
| Drug |
sofosbuvir/daclatasvir |
1 |
2015 |
| Drug |
sorafenib |
1 |
2014 |
| Drug |
sorafenib tosylate |
1 |
2014 |
| Dietary Supplement |
sorbitol |
1 |
2008 |
| Device |
speedicath |
1 |
2006 |
| Biological |
split-virion, non-adjuvanted h1n1 vaccine of 15 î¼g |
1 |
2013 |
| Biological |
split-virion, non-adjuvanted h1n1 vaccine of 30 î¼g |
1 |
2009 |
| Biological |
split, inactivated, trivalent influenza vaccine ( fluzoneâ® 2006 |
1 |
2006 |
| Biological |
split, inactivated, trivalent influenza vaccine ( fluzoneâ® 2006/2007 formulation) |
1 |
2006 |
| Device |
sponges (sponge) |
1 |
2019 |
| Dietary Supplement |
sprinkles |
1 |
2006 |
| Diagnostic Test |
sputum culture |
1 |
2017 |
| Drug |
sq ivig |
1 |
2011 |
| Other |
ssi screening tool used in home visits by chws |
1 |
2017 |
| Other |
ssi screening tool used via phone call follow-up |
1 |
2017 |
| Drug |
standard |
1 |
2016 |
| Device |
standard-of-care dressing |
1 |
2011 |
| Other |
standard-of-care infection control approach |
1 |
2014 |
| Other |
standard antibiotic stewardship |
1 |
2017 |
| Drug |
standard antibiotic therapy |
1 |
2014 |
| Drug |
standard antimicrobial therapy |
1 |
2008 |
| Other |
standard bathing |
1 |
2012 |
| Behavioral |
standard counseling |
1 |
2010 |
| Drug |
standard dose vitamin d |
1 |
2010 |
| Other |
standard dry gauze dressing |
1 |
2015 |
| Other |
standard formula |
1 |
2020 |
| Biological |
standard fresh whole blood |
1 |
2018 |
| Drug |
standard glycemic |
1 |
2013 |
| Other |
standard hospital care |
1 |
2015 |
| Other |
standard of care - chlorhexidine scrub only |
1 |
2014 |
| Drug |
standard of care antibiotics |
1 |
2015 |
| Procedure |
standard of care catheter insertion |
1 |
2017 |
| Drug |
standard of care combinational antiretroviral therapy |
1 |
2015 |
| Diagnostic Test |
standard of care early infant diagnosis |
1 |
2019 |
| Procedure |
standard operating management |
1 |
2009 |
| Procedure |
standard oxygen |
1 |
2005 |
| Other |
standard postoperative wound dressing |
1 |
2013 |
| Behavioral |
standard practices to reduce health system antibiotic prescription |
1 |
2018 |
| Procedure |
standard proctologic examination |
1 |
2014 |
| Other |
standard soap |
1 |
2018 |
| Device |
standard spc |
1 |
2011 |
| Device |
standard surgical dressing |
1 |
2014 |
| Other |
standard surgical retractors |
1 |
2015 |
| Other |
standard treatment without homeopathy |
1 |
2011 |
| Drug |
standard triple therapy |
1 |
2015 |
| Dietary Supplement |
starch of potato |
1 |
2008 |
| Other |
starter infant formula with pro |
1 |
2013 |
| Other |
starter infant formula with pro/prebiotics |
1 |
2013 |
| Procedure |
static spacer |
1 |
2011 |
| Other |
sterile bacteriology media |
1 |
2017 |
| Procedure |
sterile patient preparation for cystoscopy |
1 |
2005 |
| Other |
sterile plaster dressings |
1 |
2015 |
| Other |
sterile water |
1 |
2018 |
| Drug |
steroids |
1 |
2012 |
| Device |
stimulan rapid cure |
1 |
2017 |
| Procedure |
stool |
1 |
2016 |
| Biological |
stool collection |
1 |
2020 |
| Other |
stool sample collection |
1 |
2012 |
| Procedure |
stool/perirectal swab sampling |
1 |
2016 |
| Biological |
strain of the licensed quadrivalent vaccine |
1 |
2016 |
| Biological |
strain) |
1 |
2016 |
| Other |
strawberry fruit pieces |
1 |
2010 |
| Drug |
stribild |
1 |
2014 |
| Other |
strip peri screen |
1 |
2014 |
| Drug |
structured treatment interruptions |
1 |
2006 |
| Drug |
study group |
1 |
2018 |
| Behavioral |
style brazil |
1 |
2013 |
| Drug |
subcutaneous lenacapavir |
1 |
2019 |
| Other |
subcuticular suturing |
1 |
2012 |
| Procedure |
subinguinal microscopic varicocelectomy |
1 |
2017 |
| Device |
suction |
1 |
2013 |
| Drug |
sulbactam-etx2514 |
1 |
2018 |
| Drug |
sulbactam sodium |
1 |
2012 |
| Drug |
sulbactam sodium for injection |
1 |
2019 |
| Drug |
sulfa ds |
1 |
2009 |
| Drug |
sulfadoxine-pyrimethamine (fansidar) |
1 |
2005 |
| Drug |
sulfadoxine pyrimethamine |
1 |
2018 |
| Drug |
sulfamethoxazole trimethoprim |
1 |
2013 |
| Drug |
sulopenem-etzadroxil |
1 |
2017 |
| Drug |
sulopenem-etzadroxil/probenecid |
1 |
2017 |
| Behavioral |
supervision |
1 |
2010 |
| Other |
supplemental oxygen (80% vs. 30%) |
1 |
2006 |
| Device |
supplemental oxygen 80% fio2 |
1 |
2011 |
| Other |
supplemental training, education |
1 |
2010 |
| Other |
supplemental training, education/hygiene |
1 |
2010 |
| Other |
supplemented formula |
1 |
2020 |
| Drug |
support treatment |
1 |
2007 |
| Device |
supporting life electronic community case management |
1 |
2016 |
| Drug |
suptavumab 30 mg |
1 |
2014 |
| Drug |
suptavumab 30 mg/kg |
1 |
2014 |
| Drug |
suptavumab 30 mg/kg- 1 dose |
1 |
2014 |
| Drug |
suptavumab 30 mg/kg - 2 doses |
1 |
2014 |
| Device |
surgery alone |
1 |
2015 |
| Drug |
susceptibility guided therapy |
1 |
2018 |
| Drug |
susceptibility test guided sequential therapy |
1 |
2009 |
| Biological |
swab |
1 |
2020 |
| Other |
sweet potatos |
1 |
2017 |
| Other |
sweetened, dried cranberries |
1 |
2010 |
| Drug |
switch to dtg |
1 |
2017 |
| Drug |
switch to dtg / ftc |
1 |
2017 |
| Drug |
switching to lpv |
1 |
2009 |
| Drug |
switching to lpv/r monotherapy (kaletra) |
1 |
2009 |
| Drug |
symbicort |
1 |
2020 |
| Behavioral |
symptom diary |
1 |
2015 |
| Combination Product |
symtuza |
1 |
2019 |
| Combination Product |
symtuza/dolutegravir |
1 |
2019 |
| Biological |
synflorix |
1 |
2012 |
| Biological |
synflorixâ„¢ |
1 |
2012 |
| Diagnostic Test |
synovial alpha-defensin assay |
1 |
2018 |
| Diagnostic Test |
synovial bacterial culture by bact |
1 |
2018 |
| Diagnostic Test |
synovial bacterial culture by bact/alert |
1 |
2018 |
| Diagnostic Test |
synovial c-reactive protein (crp) |
1 |
2018 |
| Diagnostic Test |
synovial candida spp antigen panel |
1 |
2018 |
| Diagnostic Test |
synovial cell count |
1 |
2018 |
| Diagnostic Test |
synovial cell count / differential (cbc) |
1 |
2018 |
| Diagnostic Test |
synovial enterococcus faecalis assay |
1 |
2018 |
| Diagnostic Test |
synovial gram stain |
1 |
2018 |
| Diagnostic Test |
synovial lactate assay |
1 |
2018 |
| Diagnostic Test |
synovial leukocyte esterase test strips |
1 |
2018 |
| Diagnostic Test |
synovial neutrophil elastase assay |
1 |
2018 |
| Diagnostic Test |
synovial pcr for kingella kingae |
1 |
2018 |
| Diagnostic Test |
synovial staphylococcus spp antigen panel |
1 |
2018 |
| Biological |
t cell vaccination |
1 |
2006 |
| Drug |
t3 solution |
1 |
2020 |
| Drug |
tablet cefixime |
1 |
2018 |
| Drug |
tablet cefuroxime |
1 |
2018 |
| Drug |
tablet ciprofloxacin |
1 |
2018 |
| Drug |
tablet ciprofloxacin/ tablet cefixime/ tablet cefuroxime |
1 |
2018 |
| Drug |
tablet nitrofurantoin |
1 |
2018 |
| placebo |
taf placebo |
1 |
2016 |
| Behavioral |
tailored |
1 |
2016 |
| Behavioral |
tailored oral health literacy instruction |
1 |
2010 |
| Diagnostic Test |
target enriched multiplex pcr (tem- pcr) |
1 |
2018 |
| Behavioral |
targeted infection control |
1 |
2010 |
| Drug |
tavanex |
1 |
2016 |
| placebo |
tazobactam-matching placebo |
1 |
2011 |
| Drug |
tazobactam 1000 |
1 |
2014 |
| Drug |
tazobactam 12 |
1 |
2014 |
| Drug |
tazobactam 18 |
1 |
2014 |
| Drug |
tazobactam 20 |
1 |
2014 |
| Drug |
tazobactam 30 |
1 |
2014 |
| Drug |
tazobactam sodium |
1 |
2011 |
| Other |
tb infection-screening benefiting group |
1 |
2020 |
| Drug |
td-1607 |
1 |
2013 |
| Drug |
td-1792 |
1 |
2007 |
| Drug |
tdf treatment |
1 |
2011 |
| Drug |
tdf) |
1 |
2007 |
| Drug |
tdf/3tc/efv / telmisartan |
1 |
2015 |
| Drug |
tdf/3tc/efv only |
1 |
2015 |
| Behavioral |
teach-pd training curriculum |
1 |
2018 |
| Drug |
tebipenem pivoxil hydrobromide (tbpm-pi-hbr) |
1 |
2018 |
| Drug |
tedizolid (bay119-2631) |
1 |
2014 |
| Drug |
tedizolid phophate |
1 |
2014 |
| Drug |
tedizolid phosphate |
1 |
2017 |
| Drug |
tedizolid phosphate (sivextro, bay1192631) |
1 |
2013 |
| Drug |
tedizolid phosphate 200 mg [sivextro] |
1 |
2017 |
| Procedure |
tegaderm, tegaderm hp, tegaderm chg |
1 |
2010 |
| Drug |
tegobuvir capsule |
1 |
2011 |
| Drug |
telbivudine |
1 |
2013 |
| Drug |
telithromycin (hmr3647) |
1 |
2006 |
| Drug |
tenofovir / emtricitabine / raltegravir. |
1 |
2008 |
| Drug |
tenofovir 300mg |
1 |
2010 |
| Drug |
tenofovir alafenamid fumarate |
1 |
2007 |
| Drug |
tenofovir alafenamide |
1 |
2016 |
| Drug |
tenofovir disoproxil |
1 |
2015 |
| Drug |
tenofovir disoproxil fumarate (ftc |
1 |
2007 |
| Drug |
tenofovir disoproxil fumarate (tdf) 300 mg oral daily. |
1 |
2018 |
| Drug |
tenofovir disoproxil fumarate (tdf)/lamivudine (3tc) |
1 |
2018 |
| Drug |
tenofovir disoproxil fumarate/emtricitabine |
1 |
2006 |
| Drug |
tenofovir disoproxil once daily |
1 |
2008 |
| Drug |
tenofovir disoproxil twice daily |
1 |
2008 |
| Drug |
tenofovir/emtricitabine fdc |
1 |
2013 |
| Drug |
tenofovir/emtricitabine/efavirenz |
1 |
2007 |
| Biological |
tetanus toxoids |
1 |
2001 |
| Drug |
tetr |
1 |
2015 |
| Drug |
tetra |
1 |
2015 |
| Drug |
tetracycline) |
1 |
2018 |
| Drug |
tg-873870 (nemonoxacin) |
1 |
2008 |
| Biological |
tgaac09 |
1 |
2009 |
| Other |
theo |
1 |
2015 |
| Procedure |
therapeutic conventional surgery |
1 |
2017 |
| Other |
theraworx bath wipes |
1 |
2018 |
| Drug |
thymoglobulin |
1 |
2012 |
| Drug |
tight glycemic |
1 |
2013 |
| Behavioral |
time, attention, |
1 |
2019 |
| Behavioral |
time, attention,/information-matched control |
1 |
2019 |
| Drug |
timentin |
1 |
2014 |
| Drug |
tinafas |
1 |
2016 |
| Drug |
tipranavir |
1 |
2005 |
| Drug |
tipranavir/ritonavir |
1 |
2005 |
| Other |
tissue analysis |
1 |
2015 |
| Drug |
tissue plasminogen activator (tpa) |
1 |
2018 |
| Drug |
tissue plasminogen activator (tpa)/human recombinant deoxyribonuclease (dnase) |
1 |
2018 |
| Drug |
tissue sampling (lung) |
1 |
2018 |
| Drug |
tmc278 la |
1 |
2014 |
| Drug |
tmc435 |
1 |
2013 |
| Drug |
tmp-smx |
1 |
2018 |
| Drug |
tnp-2092 |
1 |
2019 |
| Drug |
tobramycin |
1 |
2017 |
| Drug |
tobramycin inhalation solution using a pari lcâ® |
1 |
2011 |
| Drug |
tobramycin inhalation solution using a pari lcâ®/nebulizer. |
1 |
2011 |
| Drug |
tocilizumab |
1 |
2014 |
| Drug |
topical 3% hexachlorophene body wash |
1 |
2010 |
| Drug |
topical anti-infective product |
1 |
2017 |
| Drug |
topical approved anti-microbial gel |
1 |
2018 |
| Drug |
topical ointment |
1 |
2017 |
| Drug |
tp-434 |
1 |
2010 |
| Drug |
tr-701 200 mg |
1 |
2008 |
| Drug |
tr-701 300 mg |
1 |
2008 |
| Drug |
tr-701 400 mg |
1 |
2008 |
| Device |
tracoe cuff pressure controller |
1 |
2016 |
| Drug |
tradipitant |
1 |
2020 |
| Procedure |
traditional chinese acupuncture |
1 |
2007 |
| Behavioral |
training |
1 |
2010 |
| Behavioral |
training/supervision |
1 |
2010 |
| Dietary Supplement |
transfer factor |
1 |
2010 |
| Procedure |
transoral robotic surgery (tors) with neck dissection |
1 |
2019 |
| Other |
treatment as usual |
1 |
2013 |
| Drug |
treatment with anti-sti |
1 |
2008 |
| Drug |
treatment with anti-sti/anti-schistosoma regimens |
1 |
2008 |
| Drug |
tridecactide |
1 |
2020 |
| Drug |
trifluridine |
1 |
1999 |
| Drug |
trim |
1 |
2009 |
| Drug |
trim/ sulfa ds |
1 |
2009 |
| Drug |
trimethoprim-sulfamethoxazole (tmp |
1 |
2020 |
| Drug |
trimethoprim-sulfamethoxazole (tmp-smx) |
1 |
2008 |
| Drug |
trimethoprim-sulfamethoxazole (tmp/smx) |
1 |
2020 |
| Drug |
trimethoprim-sulfamethoxazole / metronidazole |
1 |
2008 |
| Drug |
trimethoprim-sulfamethoxazole/doxycycline |
1 |
2007 |
| Drug |
trimethoprim / sulfamethoxazole |
1 |
2017 |
| Drug |
triptolide wilfordii |
1 |
2018 |
| placebo |
tris buffered saline (placebo) |
1 |
2011 |
| Biological |
trivalent inactivated influenza vaccine |
1 |
2005 |
| Biological |
trivalent live attenuated seasonal influenza vaccine |
1 |
2009 |
| Biological |
trivirus specific ctls for ebv, cmv |
1 |
2008 |
| Biological |
trivirus specific ctls for ebv, cmv/adenovirus infection |
1 |
2008 |
| Drug |
trizivir |
1 |
2004 |
| Drug |
truvadaâ® |
1 |
2010 |
| Procedure |
tsvf |
1 |
2020 |
| Drug |
tuberculin purified protein derivative |
1 |
1999 |
| Procedure |
two-stage exchange joint replacement surgery |
1 |
2016 |
| Drug |
two antibiotics based on personal medication history(amoxicillin,levofloxacin, furazolidone) |
1 |
2018 |
| Other |
two controls |
1 |
2013 |
| Diagnostic Test |
two samples on each of the three sites (pharynx, rectum, urine) |
1 |
2018 |
| Drug |
two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone |
1 |
2018 |
| Drug |
two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone/tetracycline) |
1 |
2018 |
| Drug |
tygacil |
1 |
2007 |
| Biological |
typhoid vi polysaccharide |
1 |
2012 |
| Device |
tyrxâ„¢ absorbable antibacterial envelope |
1 |
2014 |
| Diagnostic Test |
ultrapro |
1 |
2017 |
| Procedure |
ultrashort heat inactivation |
1 |
2010 |
| Other |
ultraviolet-a |
1 |
2012 |
| Other |
ultraviolet-a/riboflavin |
1 |
2012 |
| Device |
umbilical catheterization (agion ) |
1 |
2012 |
| Device |
umbilical catheterization (argyletm) |
1 |
2012 |
| Drug |
universal antibiotic prophylaxis |
1 |
2013 |
| Behavioral |
untailored |
1 |
2016 |
| Biological |
upper respiratory sample |
1 |
2020 |
| Device |
urinary catheterization |
1 |
2019 |
| Procedure |
urine collection |
1 |
2012 |
| Procedure |
urine sampling |
1 |
2010 |
| Procedure |
use of air (no oxygen during surgery) |
1 |
2011 |
| Device |
use of c-reactive protein (crp) point of care test |
1 |
2013 |
| Procedure |
use of creatine monohydrate (a dietary supplement) |
1 |
2007 |
| Device |
use of plastic ring wound retractor |
1 |
2017 |
| Drug |
usual antibiotics (cloxacillin, cefazolin, daptomycin) |
1 |
2019 |
| Other |
usual clinical practice |
1 |
2018 |
| Drug |
usual practice / symbicort rapihaler |
1 |
2020 |
| Other |
uv-c light |
1 |
2012 |
| Biological |
v114 0.5x:0.5x:2x |
1 |
2014 |
| Biological |
v114 1x:1x:1x |
1 |
2014 |
| Biological |
v114 1x:1x:2x |
1 |
2014 |
| Biological |
v114 2x:1x:2x |
1 |
2014 |
| Biological |
v114 2x:2x:2x |
1 |
2014 |
| Biological |
vaccination |
1 |
2017 |
| Biological |
vaccination pneumovax 23 |
1 |
2014 |
| Biological |
vaccination ppv23 |
1 |
2014 |
| Biological |
vaccinations on day 0, day 28, |
1 |
2018 |
| Biological |
vaccinations on day 0, day 28,/day 140 |
1 |
2018 |
| Behavioral |
vaccine information pages |
1 |
2013 |
| Procedure |
vacuum assisted closure |
1 |
2015 |
| Procedure |
vaginal preparation |
1 |
2019 |
| Other |
vaginal sampling |
1 |
2016 |
| Drug |
vaginal scrub, to be applied vaginally |
1 |
2019 |
| Drug |
vaginal scrub, to be applied vaginally/perineally immediately prior to surgery. |
1 |
2019 |
| Procedure |
vaginal self-sampling |
1 |
2019 |
| Procedure |
vaginal swab |
1 |
2010 |
| Other |
vagino-perineal swab |
1 |
2014 |
| Drug |
vagitrol v |
1 |
2013 |
| Drug |
valacyclovir arrow |
1 |
2012 |
| Drug |
valacyclovir oral solution |
1 |
2012 |
| Drug |
valacyclovir tablet |
1 |
2012 |
| Drug |
valganciclovir) |
1 |
2008 |
| Drug |
valomaciclovir |
1 |
2007 |
| Drug |
vancomycin (before randomization) |
1 |
2014 |
| Drug |
vancomycin (poc) |
1 |
2010 |
| Drug |
vancomycin / linezolid |
1 |
2011 |
| Drug |
vancomycin //- aztreonam/cefazolin //- aztreonam |
1 |
2011 |
| Drug |
vancomycin antibiotic powder |
1 |
2014 |
| Drug |
vancomycin iv |
1 |
2015 |
| Drug |
vancomycin with aztreonam |
1 |
2005 |
| Drug |
vancomycin/ceftazidime |
1 |
2005 |
| Drug |
vancomycin/linezolid |
1 |
2011 |
| Drug |
vancomycin/semi-synthetic penicillins (ssps) |
1 |
2010 |
| Biological |
vaxem hib (haemophilus influenzae type b (hib) vaccine) |
1 |
2009 |
| Drug |
vch 916 |
1 |
2008 |
| Drug |
vdv |
1 |
2014 |
| Device |
vdw ultra |
1 |
2018 |
| Drug |
ve303 |
1 |
2018 |
| Biological |
vedolizumab (brand name entyvio) |
1 |
2017 |
| Procedure |
venovenous hemofiltration |
1 |
2006 |
| Drug |
veronate |
1 |
2005 |
| Drug |
very low tacrolimus |
1 |
2012 |
| Drug |
vfend - voriconazole |
1 |
2006 |
| Drug |
vfendâ®(voriconazole) iv 200mg |
1 |
2015 |
| Drug |
vibramycin (doxycyline hyclate) capsule |
1 |
2010 |
| Drug |
vicryl-plus, monocryl-plus, pds-plus (triclosan-coated sutures) |
1 |
2017 |
| Other |
vicryl, monocryl, pds (not coated with triclosan) |
1 |
2017 |
| Device |
vicrylâ® |
1 |
2016 |
| Device |
vicrylplusâ® |
1 |
2016 |
| Drug |
vidarabine |
1 |
1999 |
| Device |
vidas b.r.a.h.m.s procalcitonin test (pct) |
1 |
2017 |
| Drug |
vigamox (moxifloxacin hydrochloride ophthalmic solution) |
1 |
2007 |
| Drug |
vigamox eye drops |
1 |
2007 |
| Dietary Supplement |
vigantol oil) |
1 |
2010 |
| Biological |
viral specific ctl infusion |
1 |
2015 |
| Biological |
viral specific t-cells (vsts) |
1 |
2019 |
| Biological |
virus specific t-cell (vst) infusion |
1 |
2018 |
| Biological |
virus specific t cells (vsts) |
1 |
2017 |
| Other |
visible light only |
1 |
2012 |
| Other |
visualization tool |
1 |
2018 |
| Dietary Supplement |
vitamin d supplement |
1 |
2007 |
| Dietary Supplement |
vitamin d supplements |
1 |
2012 |
| placebo |
vitamin d3 placebo |
1 |
2012 |
| Dietary Supplement |
vitamin d3 supplementation |
1 |
2013 |
| Dietary Supplement |
vitamins |
1 |
2020 |
| placebo |
viusid placebo |
1 |
2018 |
| Dietary Supplement |
viusidâ® |
1 |
2018 |
| Drug |
vm-1500 |
1 |
2015 |
| Drug |
vm-1500/placebo |
1 |
2015 |
| Drug |
vnrx-5133 (taniborbactam) |
1 |
2019 |
| Drug |
vonoprazan |
1 |
2019 |
| Drug |
vorico injection 200mg(voriconazole) |
1 |
2015 |
| Combination Product |
vp-102 |
1 |
2019 |
| Drug |
vp-102-cantharidin topical film forming solution |
1 |
2018 |
| Device |
vp-102 applicator |
1 |
2018 |
| Combination Product |
vp-102/applicator |
1 |
2019 |
| Biological |
vp20621 |
1 |
2010 |
| Biological |
vpm1002 |
1 |
2020 |
| Biological |
vrc-hivdna009-00-vp |
1 |
2005 |
| Other |
vrc-pbspla043-00-vp |
1 |
2017 |
| Biological |
vrc-zkadna090-00-vp |
1 |
2017 |
| Other |
washcloths impregnated with 2% chlorhexidine gluconate |
1 |
2015 |
| Other |
water |
1 |
2008 |
| Other |
water (psw) |
1 |
2009 |
| Device |
water chlorination by the flogenic |
1 |
2015 |
| Other |
webinars |
1 |
2016 |
| Drug |
week sc |
1 |
2008 |
| Drug |
weekly oral cyclic antibiotic programme |
1 |
2011 |
| Drug |
weileshu |
1 |
2019 |
| Drug |
wf10 |
1 |
1999 |
| Dietary Supplement |
wheat polysaccharides |
1 |
2015 |
| Device |
wira irradiation |
1 |
2012 |
| Procedure |
with placement of a catheter |
1 |
2018 |
| Other |
with visual cue |
1 |
2018 |
| Other |
with visual cue/nurses informed |
1 |
2018 |
| Procedure |
without placement of a catheter |
1 |
2018 |
| Other |
without visual cue |
1 |
2018 |
| Other |
without visual cue/nurses informed |
1 |
2018 |
| Other |
wound assessment tool |
1 |
2016 |
| Other |
wound dressing removal. |
1 |
2016 |
| Procedure |
wound packing |
1 |
2008 |
| Device |
wound protector |
1 |
2010 |
| Diagnostic Test |
woundchek |
1 |
2019 |
| Behavioral |
written information for parents |
1 |
2006 |
| Drug |
xc221 100 mg |
1 |
2018 |
| Drug |
xc221 200 mg |
1 |
2018 |
| Drug |
xc8 100 mg |
1 |
2018 |
| Drug |
xc8 20 mg |
1 |
2018 |
| Drug |
xc8 200 mg |
1 |
2018 |
| Drug |
xf-73 |
1 |
2019 |
| Drug |
xiaoer jiebiao oral liquid |
1 |
2015 |
| Dietary Supplement |
xylitol |
1 |
2008 |
| Dietary Supplement |
xylitol / bb12 |
1 |
2008 |
| Drug |
yallaferonâ® |
1 |
2013 |
| Drug |
ying qiao san |
1 |
2009 |
| Drug |
yps |
1 |
2009 |
| Drug |
zanamivir |
1 |
2011 |
| Other |
zeolite |
1 |
2018 |
| Drug |
ziagen |
1 |
2004 |
| Drug |
zidovudine (zdv) |
1 |
2010 |
| Drug |
zidovudine/lamivudine (combivirâ®) |
1 |
2006 |
| Drug |
zinc |
1 |
2007 |
| Drug |
zmapp |
1 |
2015 |
| Drug |
zti-01 |
1 |
2016 |
| Drug |
zyvoxâ® |
1 |
2002 |
| Drug |
zyvoxâ® / linezolid |
1 |
2002 |